{"gene":"HOXB4","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1995,"finding":"Retroviral overexpression of HOXB4 in murine bone marrow cells selectively expands the most primitive hematopoietic stem cell (HSC) compartment, resulting in ~50-fold higher numbers of transplantable totipotent HSCs in primary and secondary recipients, without perturbing lineage differentiation or causing overt pathology. HOXB4 functions as a transcription factor regulating HSC self-renewal and proliferative potential.","method":"Retroviral gene transfer into murine bone marrow, serial transplantation, limit dilution assay for long-term competitive repopulating cells, in vitro colony assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean gain-of-function in primary HSCs with defined in vitro and in vivo phenotypic readouts, replicated across multiple independent labs in subsequent studies","pmids":["7622039"],"is_preprint":false},{"year":2002,"finding":"HOXB4 expression in primitive yolk-sac or embryonic stem (ES) cell-derived progenitors, combined with culture on hematopoietic stroma, induces a switch to the definitive HSC phenotype capable of long-term multilineage engraftment in lethally irradiated adults, demonstrating HOXB4 confers definitive lymphoid-myeloid engraftment potential on primitive progenitors.","method":"Retroviral HOXB4 overexpression in ES-cell and yolk-sac progenitors, stromal co-culture, transplantation into lethally irradiated mice, multilineage reconstitution assay in primary and secondary recipients","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct in vivo engraftment assay with primary and secondary recipients, replicated by multiple independent groups","pmids":["11955444"],"is_preprint":false},{"year":2002,"finding":"HOXB4 overexpression in murine bone marrow enables over 1000-fold higher HSC levels relative to controls and a 40-fold net HSC increase ex vivo, with HSCs retaining full lympho-myeloid repopulating potential, establishing HOXB4 as a potent positive regulator of HSC self-renewal ex vivo.","method":"Retroviral HOXB4 transduction of murine bone marrow, 10-14 day expansion culture, limit dilution competitive repopulating unit (CRU) assay, transplantation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — quantitative CRU assay with transplantation, independently confirmed by multiple labs","pmids":["11955445"],"is_preprint":false},{"year":1998,"finding":"Cellular transformation and proliferation induced by HOXB4 (and HOXB3) in Rat-1 fibroblasts requires cooperation with PBX1; the transforming capacity depends on the conserved tetrapeptide (HOX-PBX interaction domain) and the homeodomain (DNA-binding domain). Modulating PBX1 levels directly modulates HOXB4-induced transformation.","method":"Rat-1 fibroblast transformation assay, overexpression and knockdown of PBX1, HOXB4 point mutants lacking tetrapeptide or homeodomain function","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis of functional domains combined with cellular transformation assay and PBX1 modulation, single lab but multiple orthogonal approaches","pmids":["9692548"],"is_preprint":false},{"year":2003,"finding":"Recombinant TAT-HOXB4 protein (carrying the HIV-TAT protein transduction domain) directly transduces into HSCs and expands murine HSCs ~4–6 fold ex vivo, comparable to retroviral HOXB4, demonstrating that HOXB4 protein itself (not just gene expression) is sufficient to drive HSC expansion and that the protein passively translocates across cell membranes.","method":"Recombinant protein production, protein transduction into murine bone marrow HSCs, competitive repopulation assay in transplanted mice","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein delivery (circumventing gene transfer) with in vivo CRU assay, replicated by independent lab (PMID:14578882)","pmids":["14578881","14578882"],"is_preprint":false},{"year":2003,"finding":"Human HSCs (LTC-ICs and NOD-SCID repopulating cells) can be expanded >20-fold (LTC-IC) and >2.5-fold (SRC) by HOXB4 protein delivered via stromal cells engineered to secrete it, confirming the membrane-translocating property of the HOXB4 homeoprotein and its ability to expand human HSCs without genetic modification.","method":"Stromal cells engineered to secrete HOXB4, co-culture with human HSCs, LTC-IC assay, NOD-SCID repopulation assay","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein delivery to human HSCs with in vivo repopulation assay, independent replication of TAT-HOXB4 approach","pmids":["14578882"],"is_preprint":false},{"year":2003,"finding":"HOXB4-induced HSC expansion in vivo is limited by the availability of PBX1: knockdown of PBX1 in HOXB4-overexpressing HSCs generates 'ultra-competitive' HSCs that are >20-fold more competitive than HOXB4-alone cells, yet still do not exceed normal HSC pool size in vivo, suggesting a non-cell-autonomous mechanism limits expansion.","method":"Retroviral overexpression of HOXB4 combined with PBX1 shRNA knockdown in murine bone marrow, competitive transplantation, multilineage reconstitution","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Moderate — epistasis via combined gain-of-function (HOXB4) and loss-of-function (PBX1 KD) with in vivo competitive repopulation, single lab","pmids":["12705858"],"is_preprint":false},{"year":2004,"finding":"HOXB4-induced HSC expansion requires direct DNA binding by HOXB4: a DNA-binding-incompetent HOXB4 mutant (HOXB4-A) fails to enhance HSC proliferation in vitro or expansion in vivo. Conversely, a mutant lacking HOX-PBX cooperative DNA binding (HOXB4-W→G) retains and even enhances in vitro proliferation and in vivo expansion, demonstrating that HOXB4 acts through direct DNA binding independent of HOX-PBX cooperative interaction.","method":"Retroviral overexpression of HOXB4 point mutants (DNA-binding-incompetent and PBX-interaction-deficient) in murine bone marrow, in vitro proliferation assay, in vivo competitive repopulation","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Moderate — active-site mutagenesis with defined functional readouts in primary cells and in vivo, single lab but two orthogonal mutant analyses","pmids":["15226173"],"is_preprint":false},{"year":2000,"finding":"HOXB4 transcription in human hematopoietic cells is activated through an E-box binding site (HXRE-2) in its promoter by USF-1 and USF-2 transcription factors acting via the MAP kinase pathway; USF-2 was identified by yeast one-hybrid screen of bone marrow library. MITF binds the same site but does not activate the promoter.","method":"Promoter deletion/mutation analysis, yeast one-hybrid screen, EMSA, co-transfection luciferase assays in K562 and CD34+ cells, MAP kinase pathway inhibition","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple complementary approaches (yeast one-hybrid, EMSA, mutagenesis, co-transfection) in primary and cell line contexts","pmids":["11085749"],"is_preprint":false},{"year":2003,"finding":"The trimeric NF-Y complex binds the HxRE-1 site of the HOXB4 promoter, activates HOXB4 transcription in hematopoietic cells, and physically interacts with USF1/2 on the HOXB4 promoter; NF-Y occupancy on the HOXB4 promoter is reduced during granulocytic differentiation as NF-Ya levels decline, suggesting NF-Y is a developmentally regulated inducer of HOXB4.","method":"Promoter analysis, EMSA, ChIP assay, co-transfection with dominant-negative NF-Y subunits, co-immunoprecipitation of NF-Y/USF1/2 complex","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — ChIP in primary cells + EMSA + co-IP + functional promoter assays, multiple orthogonal methods, single lab","pmids":["12791656"],"is_preprint":false},{"year":1998,"finding":"Hoxb4 rhombomeric expression in the vertebrate hindbrain is initiated by transient signaling from paraxial mesoderm (somites) through a retinoid pathway requiring retinoic acid receptor (RAR) function within the neural plate; a retinoic acid response element (RARE) within a prerhombomeric enhancer of Hoxb4 is essential for this neural response and interprets positional information for setting the anterior boundary of expression.","method":"Chick/mouse embryo tissue transposition, RAR inhibition in neural plate, enhancer-reporter transgenic mice, mutagenesis of RA response element","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — enhancer mutagenesis in transgenic mice combined with embryological tissue manipulations and RAR pathway interference","pmids":["9697850"],"is_preprint":false},{"year":1995,"finding":"Compound mutants for paralogous group 4 Hox genes (hoxa-4, hoxb-4, hoxd-4) show more complete and dose-dependent homeotic transformations of cervical vertebrae than single mutants, demonstrating functional redundancy among paralogous genes and revealing a larger anteroposterior domain of requirement than single mutants indicate.","method":"Targeted gene disruption in mice (gene targeting), generation of double and triple Hox group 4 compound mutants, skeletal phenotype analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via compound null mutants, clear dose-dependent phenotypic series","pmids":["7628700"],"is_preprint":false},{"year":1999,"finding":"HOXB4-overexpressing HSCs regenerate to fully reconstitute the HSC compartment post-transplantation (14-fold more HSCs than control transplants) but do not expand above normal HSC levels found in unmanipulated mice, indicating that HOXB4 overexpression does not override homeostatic mechanisms controlling HSC pool size.","method":"Murine bone marrow transplantation with HOXB4-retroviral transduced cells, HSC quantification by competitive repopulation over 12 months","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — long-term in vivo quantification of HSC pool size with multiple cohorts, establishes a ceiling on HOXB4-mediated expansion","pmids":["10515864"],"is_preprint":false},{"year":2003,"finding":"Hematopoietic expression of HOXB4 is regulated by thrombopoietin (TPO) via the p38 MAP kinase pathway, which induces upstream stimulating factor-1 (USF-1), which in turn activates HOXB4 transcription; TPO-null mice have 2–5-fold lower Hoxb4 expression in candidate HSCs.","method":"TPO stimulation of primitive hematopoietic cell lines, p38 MAPK pharmacological inhibition, comparison of tpo-/- and control mouse HSC Hoxb4 mRNA levels, USF-1 activation assays","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cytokine-to-kinase-to-transcription factor pathway established by pharmacological inhibition and genetic null model, single lab","pmids":["12855555"],"is_preprint":false},{"year":2009,"finding":"Cytoplasmic Prep1 interacts with 4EHP (eukaryotic translation initiation factor 4E homolog protein) in mouse oocytes and together they repress translation of Hoxb4 mRNA by Prep1 binding to the Hoxb4 3'UTR; a functional 4EHP-binding motif in Prep1 is required for this repression. Hoxb4 is overproduced in hypomorphic Prep1 oocytes, establishing Prep1-4EHP as a translational repressor of Hoxb4.","method":"Confocal microscopy/co-localization, co-immunoprecipitation, pulldown, site-directed mutagenesis of 4EHP-binding motif, in vitro translation assay with luciferase-Hoxb4-3'UTR reporter, RNA EMSA, immunohistochemistry in Prep1 hypomorphic mice","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (co-IP, pulldown, mutagenesis, in vitro translation, EMSA) in single study establishing a translational regulatory mechanism","pmids":["19365557"],"is_preprint":false},{"year":2003,"finding":"Multiple regulatory elements control Hoxb4 mesodermal expression: an intronic enhancer (region C) is sufficient for temporal activation and setting the anterior somitic boundary (somite 6/7), but the Hoxb4 promoter is required to maintain expression beyond E8.5; sequences in the 3'UTR (region B) are necessary specifically to maintain expression in somite 7 from E9.0 onward. Post-transcriptional regulation including transcript stability and selective protein translation/degradation also restricts the Hoxb4 expression domain.","method":"Transgenic mouse reporter analysis with defined regulatory element deletions, in situ hybridization, developmental time-course analysis","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic dissection of regulatory elements in transgenic mice with multiple constructs, single lab","pmids":["12736215"],"is_preprint":false},{"year":2002,"finding":"An intron enhancer of mouse Hoxb4 requires binding by NFY (at an NFY/YY1 overlapping motif) for its activity in establishing the anterior boundary of mesodermal expression; specific mutations abolishing NFY binding eliminate enhancer activity. The same NFY/YY1 motif is present in the Hoxb4 promoter, suggesting relative NFY vs YY1 occupancy as a mechanism for balancing activation and repression.","method":"Heterologous promoter-reporter assays, site-directed mutagenesis of NFY and YY1 binding sites, transgenic mouse assay for anterior boundary of mesodermal expression","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis in transgenic mice with functional boundary readout, single lab","pmids":["12135926"],"is_preprint":false},{"year":1994,"finding":"The Hoxb-4 promoter contains multiple positive and negative regulatory elements: two cell-type-specific negative regulatory elements (regions a and d), an additional negative element (region b), and a positive element binding a novel factor HoxTF at sequence GCCATTGG that is essential for efficient Hoxb-4 expression; two 12-bp initiator elements flank each of the two transcription start sites (P1 and P2).","method":"Nuclease S1 and primer extension mapping of transcription start sites, detailed promoter mutagenesis with CAT reporter assays in multiple cell lines","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — systematic promoter mutagenesis with reporter assays, single lab, in vitro context","pmids":["7969151"],"is_preprint":false},{"year":1999,"finding":"HOXB4 is identified as a 1,25-dihydroxyvitamin D3-inducible protein that binds to the MIE1 site in c-myc intron 1 and participates in blocking c-myc transcriptional elongation during HL-60 monocytic differentiation; the MIE1 and MIE2/MIE3 sites are required for D3-mediated suppression of c-myc, and this binding activity requires PKCβ signaling.","method":"CAT reporter assays with c-myc promoter constructs containing deletions/mutations of MIE sites, gel-shift/EMSA, protein identification of MIE1-binding protein as HOXB4, PKCβ antisense and pharmacological inhibition","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA protein identification + functional reporter assays + PKC inhibition, single lab, HL-60 cell system","pmids":["10085075"],"is_preprint":false},{"year":2001,"finding":"Antisense knockdown of HOXB4 partially blocks 1,25-dihydroxyvitamin D3-mediated suppression of c-myc and inhibits HL-60 differentiation, establishing that endogenous HOXB4 is functionally required downstream of vitamin D3 signaling to suppress c-myc transcription elongation.","method":"Phosphorothioate antisense oligonucleotide knockdown of HOXB4, c-myc protein level measurement, HL-60 differentiation assays (NBT and non-specific esterase)","journal":"The Journal of endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function antisense with defined molecular and cellular phenotype readouts, corroborates gain-of-function data from companion paper","pmids":["11250656"],"is_preprint":false},{"year":2010,"finding":"Hemogen (Hemgn), a hematopoietic-specific nuclear protein, is a direct transcriptional target of HOXB4: HOXB4 binds to the Hemgn promoter region both ex vivo and in vivo (ChIP). Overexpression of Hemgn partially recapitulates HOXB4-mediated myeloid progenitor expansion, and shRNA knockdown of Hemgn reduces HOXB4-mediated expansion.","method":"Tamoxifen-inducible HOXB4-ER(T2) system in lineage-negative murine bone marrow, expression microarrays, ChIP assay for HOXB4 binding to Hemgn promoter, Hemgn overexpression and shRNA knockdown with myeloid colony assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct target validated by ChIP + inducible system + gain-of-function + loss-of-function, single lab but multiple orthogonal approaches","pmids":["20393131"],"is_preprint":false},{"year":2013,"finding":"CUL4 ubiquitin ligase mediates post-translational degradation of HOXB4 protein through a conserved degradation signal sequence (degron) in the homeodomain, giving HOXB4 a short protein half-life (~1 hour). A CUL4-resistant (degradation-resistant) HOXB4 mutant has enhanced activity in expanding myeloid progenitors and better maintains human HSCs in a primitive state in vitro and in vivo. This degron is conserved in additional HOX paralogues.","method":"Co-immunoprecipitation of HOXB4 with CUL4, degron mapping by deletion mutagenesis, protein stability assays, engineered degradation-resistant HOXB4 variants, human HSC transduction and NOD/SCID/IL2Rγ-null mouse transplantation","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — co-IP identifies E3 ligase, mutagenesis maps degron, functional rescue with engineered variant in primary human HSCs and in vivo, single lab with multiple orthogonal methods","pmids":["23520338"],"is_preprint":false},{"year":2010,"finding":"Hoxb4 transduction reduces accumulated Geminin protein in hematopoietic stem and progenitor cells through constituting an E3 ubiquitin ligase complex (RDCOXB4) with Roc1-Ddb1-Cul4a, targeting Geminin for ubiquitin-proteasome degradation; Geminin knockdown promotes clonogenic/replating activity while Geminin overexpression suppresses HOXB4-mediated HSC expansion.","method":"Co-immunoprecipitation of HOXB4 with Roc1-Ddb1-Cul4a complex in vitro and in vivo, ubiquitination assays, Geminin overexpression and knockdown, competitive repopulation in Rae28-deficient mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — co-IP identifies complex + functional overexpression/knockdown of downstream target, single lab","pmids":["21098278"],"is_preprint":false},{"year":2013,"finding":"USF1 directs recruitment of the hSET1A histone H3K4 methyltransferase complex to the HoxB4 promoter, establishing H3K4me3 marks and activating HoxB4 transcription during ESC differentiation toward hematopoietic lineages; disruption of USF1 or hSET1A function reduces HoxB4 expression and impairs mesoderm/hematopoietic differentiation.","method":"ChIP for H3K4me3 and USF1/hSET1A at HoxB4 promoter, dominant-negative USF1 overexpression, RNA interference knockdown of hSET1A, ESC differentiation assays","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP + gain/loss-of-function in ESC differentiation context, single lab","pmids":["23754954"],"is_preprint":false},{"year":2003,"finding":"The TALE homeodomain gene Irx5 is a direct, positively regulated transcriptional target of Hoxb4 in the developing chick embryo.","method":"Gain- and loss-of-function manipulation of Hoxb4 in chick embryos with direct readout of Irx5 expression","journal":"Developmental dynamics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single experimental system (chick embryo), limited mechanistic detail in abstract, single lab","pmids":["12701098"],"is_preprint":false},{"year":2004,"finding":"Hoxb4 directly induces expression of FLASH (a component of the FAS-CASPASE8 apoptotic pathway) in the notochord after neurulation; blocking FLASH activity or Hoxb4 activity prevents apoptosis in the notochord.","method":"Gain- and loss-of-function manipulations of Hoxb4 and FLASH in developing embryos (chick), direct readout of FLASH expression and notochord apoptosis","journal":"Developmental biology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — functional epistasis in developmental context (chick embryo) with limited mechanistic detail in abstract, single lab","pmids":["14697356"],"is_preprint":false},{"year":2004,"finding":"Mice homozygous for Hoxb4 deficiency exhibit mildly reduced hematopoietic organ cellularity and impaired proliferative responses of Lin-Sca1+c-kit+ bone marrow stem/progenitor cells in vitro and in vivo after transplantation, with altered expression of other Hox genes and cell cycle regulators. Hoxb4 is not required for HSC generation or steady-state hematopoiesis.","method":"Hoxb4 complete knockout mouse model, flow cytometry, competitive transplantation, in vitro culture proliferation, quantitative mRNA analysis, cell cycle assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean gene knockout with multiple functional readouts (proliferation, transplantation, cell cycle), independently complemented by Hoxb3/b4 double KO paper","pmids":["14962901"],"is_preprint":false},{"year":2003,"finding":"Hoxb3/Hoxb4 double-deficient mice have reduced hematopoietic stem cell pool in fetal liver and impaired proliferative capacity of Lin-Sca1+c-kit+ progenitors in vitro and in vivo; slower cell cycle kinetics confer increased tolerance to anti-mitotic drugs, establishing a direct physiological role for Hoxb4 (with Hoxb3) in regulating stem cell proliferation and regeneration.","method":"Hoxb3/Hoxb4 compound knockout mice, competitive repopulation assay, homing assay, cytostatic drug challenge, flow cytometry, colony assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — compound knockout with multiple functional and mechanistic readouts, clean genetic design","pmids":["12748289"],"is_preprint":false},{"year":2007,"finding":"HOXB4 activity protects adult HSCs from the detrimental anti-proliferative effects of TNF-α; FGF signaling interacts with HOXB4 activity in a context-dependent manner (FGF receptor inhibition enhances HOXB4-mediated expansion of adult and ES-derived HSCs, while FGF2 has a dominant-negative effect on the earliest hematopoietic cells). These findings establish that HOXB4 modulates HSC responses to extrinsic signals.","method":"Gene expression profiling of inducible HOXB4 in enriched adult HSCs and embryonic derivatives, functional assays with TNF-α treatment and FGF receptor inhibition, competitive repopulation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transcriptome profiling combined with functional validation of specific pathways, single lab","pmids":["17940039"],"is_preprint":false},{"year":2011,"finding":"Genome-wide ChIP and expression profiling in ES-cell-derived HSPCs identifies Runx1, Scl/Tal1, Gata2, and Gfi1 as direct transcriptional targets of HoxB4, and reveals indirect regulation of Lmo2, Erg, Meis1, Pbx1, Nov, AhR, and Hemgn. HoxB4 acts predominantly as a transcriptional activator but context-dependently represses a significant subset of direct targets.","method":"ChIP-seq (ChIP coupled with deep sequencing) and genome-wide expression profiling in ES-derived hematopoietic stem/progenitor cells expressing inducible HoxB4","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq with expression profiling identifies direct targets, single lab, limited functional validation per target in abstract","pmids":["21343615"],"is_preprint":false},{"year":2012,"finding":"Dynamic ChIP-seq and gene expression profiling across four stages of HoxB4-mediated ESC differentiation toward HSCs reveals that the HoxB4 regulatory network expands progressively, HoxB4 co-regulates multiple hematopoietic transcription factors (Fli1, Meis1, Runx1, Scl) in distinct combinations, and down-regulation of mitochondrial and lysosomal genes by HoxB4 may contribute to impaired lymphoid development.","method":"ChIP coupled with deep sequencing and global gene expression profiling at 4 differentiation stages, joint bioinformatic analysis","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multi-stage ChIP-seq + expression profiling, single lab, mechanistic conclusions are correlative at the network level","pmids":["22438249"],"is_preprint":false},{"year":2014,"finding":"Prdm16 mRNA is markedly repressed as a direct component of the HOXB4 transcriptional program in transplanted HSCs; enforced co-expression of sPrdm16 with HOXB4 leads to enhanced self-renewal, myeloid expansion, and leukemia, establishing Prdm16 downregulation as a specific mechanism by which HOXB4-expanding HSCs avoid leukemic transformation.","method":"Time-course gene expression profiling of Lin-Sca1+c-kit+ cells from HOXB4-transplanted mice, co-overexpression of sPrdm16 with HOXB4 by retroviral transduction, murine transplantation leukemia model","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — expression profiling plus functional epistasis (co-expression) with leukemia readout, single lab","pmids":["25082879"],"is_preprint":false},{"year":2014,"finding":"HoxB4 and STAT3 act in the same pathway for HSC self-renewal: simultaneous transduction of both does not produce additive effects; inhibition of STAT3 in HoxB4-overexpressing cells abrogates HoxB4 enhancement; HoxB4 upregulation causes ligand-independent Tyr-phosphorylation of STAT3; and the two transcription factors regulate significantly overlapping transcriptomes including pluripotency-related genes Oct-4 and Nanog.","method":"Retroviral co-transduction of STAT3-C and HoxB4, competitive repopulation assay, STAT3 pharmacological inhibition, phospho-STAT3 Western blot, microarray transcriptome analysis, gene set enrichment analysis","journal":"Stem cells (Dayton, Ohio)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis by co-expression and inhibition plus phosphorylation assay and transcriptome overlap, single lab","pmids":["24446131"],"is_preprint":false},{"year":2013,"finding":"miR-23a directly binds the 3'UTR of HOXB4 mRNA and represses HOXB4 protein expression by ~65%, as demonstrated by luciferase reporter assay and Western blot.","method":"Luciferase 3'UTR reporter assay with miR-23a, Western blot for HOXB4 protein after miR-23a transfection","journal":"Genes, chromosomes & cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase 3'UTR assay plus Western blot validation, single lab","pmids":["23630040"],"is_preprint":false},{"year":2016,"finding":"A proline-rich sequence near the N-terminus of HOXB4, unique among HOX proteins and highly conserved in higher mammals, is required for controlled stem cell amplification: deletion of this domain substantially enhances HOXB4's oncogenicity causing acute leukemia in mice; insertion of the domain into HOXA9 impairs HOXA9's leukemogenicity.","method":"Domain deletion and domain-swap mutagenesis of HOXB4/HOXA9, retroviral transduction into murine bone marrow, transplantation with leukemia monitoring, in vivo stem cell expansion assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — domain mutagenesis with reciprocal domain-swap between paralogs + in vivo leukemia readout, establishes clear structure-function relationship","pmids":["27827825"],"is_preprint":false},{"year":2019,"finding":"IGF2BP1 maintains HOXB4 mRNA stability in leukemia cells; IGF2BP1 inhibition reduces HOXB4 expression and decreases leukemia cell tumorigenicity, myeloid differentiation block, and chemotherapy resistance.","method":"CLIP and PAR-CLIP to identify HOXB4 as an IGF2BP1 RNA target, gain- and loss-of-function systems for IGF2BP1 in leukemia cell lines, tumor-initiating potential assays","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CLIP/PAR-CLIP identifying mRNA target + gain/loss-of-function functional assays, single lab","pmids":["31768017"],"is_preprint":false},{"year":2021,"finding":"HOXB4 directly transcriptionally represses β-catenin expression, thereby inactivating the Wnt/β-catenin signaling pathway in cervical cancer cells; re-expression of β-catenin rescues HOXB4-induced growth inhibition.","method":"ChIP or reporter assays for HOXB4 binding to β-catenin promoter, gain/loss-of-function of HOXB4 in cervical cancer cells, β-catenin rescue experiment, nude mouse xenograft","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic rescue experiment + binding assay + in vivo xenograft, single lab","pmids":["33479226"],"is_preprint":false},{"year":2020,"finding":"HOXB4 activates DHDDS transcription by binding to two DNA motifs in the DHDDS gene, contributing to ovarian cancer proliferation and invasion; HOXB4 also induces Snail and Zeb1 expression (EMT markers).","method":"ChIP assay for HOXB4 binding to DHDDS promoter motifs, HOXB4 gain/loss-of-function in ovarian cancer cells, xenograft mouse model","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP validates direct target binding + functional gain/loss-of-function + in vivo xenograft, single lab","pmids":["32178630"],"is_preprint":false},{"year":2024,"finding":"HOXB4 binds to the LINC00629 promoter and transcriptionally represses LINC00629 expression in ovarian cancer cells.","method":"ChIP assay for HOXB4 binding to the LINC00629 promoter, correlation of HOXB4 expression with LINC00629 levels","journal":"Cancer science","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single ChIP assay, limited functional validation of HOXB4's direct role distinct from downstream lncRNA effects","pmids":["38182548"],"is_preprint":false},{"year":2021,"finding":"HOXB4 serves as a transcriptional activator of AKR1C3 and can suppress erastin-induced ferroptosis in H9C2 cardiomyocytes.","method":"Luciferase reporter assay for HOXB4 transactivation of AKR1C3, ferroptosis characteristic measurements (GPX4, MDA, iron, GSH) in HOXB4-transfected H9C2 cells","journal":"Frontiers in cardiovascular medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single reporter assay + cellular ferroptosis measurements, single lab, limited mechanistic detail","pmids":["34568444"],"is_preprint":false},{"year":2018,"finding":"HOXB4 promotes hemogenic endothelium formation from differentiating mouse ESCs without altering endothelial cell development; whole-transcriptome analysis shows HOXB4 upregulates core hematopoietic transcription factors at the hemogenic endothelium stage, with blood progenitor formation requiring subsequent Runx1 expression.","method":"Retroviral HOXB4 expression in Runx1-/- ESCs with doxycycline-inducible Runx1, flow cytometric identification of hemogenic endothelium, whole-transcriptome analysis","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic dissection using Runx1-null ESCs + inducible Runx1 + transcriptome analysis identifies specific cellular stage of HOXB4 action, single lab","pmids":["29456178"],"is_preprint":false},{"year":2008,"finding":"HOXB4 overexpression in large animals (dogs, macaques) caused myeloid leukemia ~2 years post-transplantation with dysregulated oncogene expression and a block in myeloid differentiation; HOXB4 knockdown in leukemic cells restored differentiation, suggesting direct HOXB4 involvement. Control gammaretroviral vectors (expressing MGMT or no transgene) did not cause leukemia.","method":"Retroviral HOXB4 transduction in large animal HSCs (dog, macaque), long-term transplantation monitoring, leukemia characterization (blast immunophenotyping, oncogene expression profiling), HOXB4 shRNA knockdown of leukemic cells","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — large animal model with long-term follow-up + HOXB4 knockdown rescue of differentiation block, small animal numbers limit strength","pmids":["18357342"],"is_preprint":false}],"current_model":"HOXB4 is a homeodomain transcription factor that promotes hematopoietic stem cell self-renewal and expansion through direct DNA binding (independent of HOX-PBX cooperative interaction); its transcription is activated by USF1/USF2 (via MAP kinase and p38 pathways) and NF-Y at its promoter, while Prep1-4EHP represses its translation via the 3'UTR; at the protein level, HOXB4 is rapidly degraded by the CUL4 ubiquitin ligase through a conserved homeodomain degron, and also forms an E3 ligase complex (RDCOXB4 with Roc1-Ddb1-Cul4a) to ubiquitinate Geminin and promote HSC proliferation; its direct transcriptional targets include hematopoietic master regulators (Runx1, Scl/Tal1, Gata2, Gfi1) and downstream effectors such as Hemgn, and it represses Prdm16 to prevent leukemic transformation; a unique N-terminal proline-rich domain restrains its oncogenic potential; in non-hematopoietic contexts HOXB4 directly represses β-catenin (Wnt pathway) and activates DHDDS and AKR1C3 transcription, and during hindbrain development it is induced by somite-derived retinoic acid signaling through a RARE in its prerhombomeric enhancer."},"narrative":{"mechanistic_narrative":"HOXB4 is a homeodomain transcription factor that acts as a master positive regulator of hematopoietic stem cell (HSC) self-renewal and proliferation, expanding the most primitive transplantable HSC compartment without disrupting lineage differentiation [PMID:7622039, PMID:11955445]. Its expansion activity requires direct DNA binding by the homeodomain but is independent of, and even enhanced by loss of, the HOX-PBX cooperative interaction [PMID:15226173]; the protein is membrane-permeant, such that recombinant or stroma-secreted HOXB4 expands both murine and human HSCs without genetic modification [PMID:14578881, PMID:14578882]. Crucially, HOXB4 does not override homeostatic ceilings on HSC pool size, restoring rather than exceeding normal HSC numbers in vivo [PMID:10515864], and loss-of-function studies show it is dispensable for HSC generation yet required for full proliferative capacity of stem/progenitor cells, acting redundantly with paralogous group-4 Hox genes [PMID:14962901, PMID:12748289, PMID:7628700]. Mechanistically, HOXB4 directly binds and activates a network of hematopoietic master regulators—Runx1, Scl/Tal1, Gata2, Gfi1—and the downstream effector Hemgn, while acting context-dependently as a repressor of a subset of targets [PMID:21343615, PMID:20393131]; it drives hemogenic endothelium formation upstream of Runx1 [PMID:29456178] and signals through a shared pathway with STAT3 [PMID:24446131]. HOXB4 transcription is controlled at its promoter by USF1/USF2 acting through MAP kinase/p38 signaling downstream of thrombopoietin, with USF1 recruiting the hSET1A H3K4 methyltransferase complex, and by the trimeric NF-Y complex, which physically associates with USF1/2 [PMID:11085749, PMID:12855555, PMID:12791656, PMID:23754954]. The protein is held under tight control: it has a short half-life imposed by CUL4-mediated ubiquitination of a conserved homeodomain degron [PMID:23520338], and it conversely assembles a Roc1-Ddb1-Cul4a E3 ligase complex to degrade Geminin and promote proliferation [PMID:21098278]. HOXB4 limits its own oncogenic potential through a unique conserved N-terminal proline-rich domain and by repressing Prdm16, with deletion of the proline-rich domain or co-expression of Prdm16 converting HOXB4 into a leukemogenic driver [PMID:27827825, PMID:25082879, PMID:18357342]. In non-hematopoietic and developmental contexts, HOXB4 expression is initiated in the hindbrain by somite-derived retinoic acid acting through a RARE in a prerhombomeric enhancer [PMID:9697850], and it functions as a context-dependent transcriptional regulator, directly repressing β-catenin to inhibit Wnt signaling in cervical cancer and activating DHDDS in ovarian cancer [PMID:33479226, PMID:32178630].","teleology":[{"year":1995,"claim":"Established the foundational function of HOXB4 by asking whether a HOX gene could regulate HSC numbers, showing it selectively expands the primitive stem cell compartment.","evidence":"Retroviral overexpression in murine bone marrow with serial transplantation and limit-dilution repopulation assays","pmids":["7622039"],"confidence":"High","gaps":["Direct transcriptional targets unidentified","Mechanism distinguishing self-renewal from differentiation unclear"]},{"year":1995,"claim":"Defined the physiological developmental role and revealed functional redundancy by asking what group-4 Hox genes are required for, showing dose-dependent vertebral transformations only in compound mutants.","evidence":"Targeted gene disruption generating double and triple Hox group-4 compound mutant mice with skeletal analysis","pmids":["7628700"],"confidence":"High","gaps":["Does not address hematopoietic requirement","Molecular targets in skeletal patterning not defined"]},{"year":1998,"claim":"Addressed how HOXB4 is positioned in the embryo by identifying the upstream inducing signal, showing retinoic acid from somites sets the anterior expression boundary via a RARE.","evidence":"Chick/mouse tissue transposition, RAR inhibition, and enhancer-reporter transgenics with RARE mutagenesis","pmids":["9697850"],"confidence":"High","gaps":["Hematopoietic regulation distinct from this neural enhancer","Downstream neural targets not defined"]},{"year":1998,"claim":"Tested which protein domains mediate HOXB4 activity in a transformation context, showing dependence on both the tetrapeptide HOX-PBX interaction domain and the homeodomain.","evidence":"Rat-1 fibroblast transformation assay with HOXB4 domain mutants and PBX1 modulation","pmids":["9692548"],"confidence":"High","gaps":["Fibroblast transformation may not reflect HSC mechanism","PBX1 requirement later shown dispensable in HSCs"]},{"year":2002,"claim":"Asked whether HOXB4 acts ex vivo and on embryonic progenitors, demonstrating massive ex vivo HSC expansion and conferral of definitive engraftment potential on primitive progenitors.","evidence":"Retroviral overexpression in bone marrow, ES/yolk-sac progenitors, stromal co-culture, and competitive repopulation assays","pmids":["11955444","11955445"],"confidence":"High","gaps":["Transcriptional program driving expansion unknown","Mechanism of definitive switch not resolved"]},{"year":2003,"claim":"Resolved whether HOXB4 protein itself suffices, showing membrane-permeant recombinant and stroma-secreted HOXB4 expand murine and human HSCs without gene transfer.","evidence":"TAT-HOXB4 protein transduction and stroma-secreted HOXB4 co-culture with murine and human HSCs, in vivo repopulation","pmids":["14578881","14578882"],"confidence":"High","gaps":["Mechanism of passive membrane translocation not detailed","Magnitude lower than retroviral delivery"]},{"year":2003,"claim":"Connected HOXB4 transcription to extrinsic cytokine signaling by showing thrombopoietin induces it via p38 MAPK and USF-1.","evidence":"TPO stimulation, p38 inhibition, USF-1 activation assays, and tpo-/- mouse mRNA quantification","pmids":["12855555"],"confidence":"Medium","gaps":["Single lab","Quantitative contribution of TPO to physiological HOXB4 levels modest (2-5 fold)"]},{"year":2000,"claim":"Identified the proximal transcriptional activators of HOXB4 by asking what binds its promoter E-box, showing USF-1/USF-2 activate via the MAP kinase pathway.","evidence":"Yeast one-hybrid screen, EMSA, promoter mutagenesis, and luciferase assays in K562/CD34+ cells","pmids":["11085749"],"confidence":"High","gaps":["MITF binds the same site without activating, function unexplained","In vivo promoter occupancy not addressed"]},{"year":2003,"claim":"Expanded the promoter model by identifying NF-Y as a developmentally regulated activator that physically partners with USF1/2.","evidence":"EMSA, ChIP, dominant-negative NF-Y, and co-immunoprecipitation of NF-Y/USF1/2","pmids":["12791656"],"confidence":"High","gaps":["Mechanism linking NF-Ya decline to differentiation incomplete"]},{"year":2003,"claim":"Determined the dominant domain requirement for HSC expansion in vivo, showing direct DNA binding is essential while HOX-PBX cooperativity is dispensable and limiting.","evidence":"Retroviral DNA-binding-incompetent and PBX-interaction-deficient HOXB4 mutants with PBX1 knockdown and competitive repopulation","pmids":["15226173","12705858"],"confidence":"High","gaps":["Non-cell-autonomous mechanism limiting expansion unidentified","Direct in vivo target genes not yet mapped"]},{"year":1999,"claim":"Established a non-self-renewal transcriptional function by asking how vitamin D3 suppresses c-myc, identifying HOXB4 as the MIE1-binding factor blocking c-myc elongation.","evidence":"EMSA protein identification, c-myc reporter assays, PKCβ inhibition, and antisense HOXB4 knockdown in HL-60","pmids":["10085075","11250656"],"confidence":"Medium","gaps":["Single cell-line system","Relationship to HSC role unclear"]},{"year":2009,"claim":"Revealed translational control of HOXB4 by showing cytoplasmic Prep1-4EHP represses Hoxb4 mRNA via its 3'UTR.","evidence":"Co-IP, pulldown, 4EHP-motif mutagenesis, in vitro translation with Hoxb4-3'UTR reporter, and Prep1 hypomorph mice","pmids":["19365557"],"confidence":"High","gaps":["Demonstrated in oocytes; relevance to hematopoiesis untested","Single study"]},{"year":2010,"claim":"Began defining the HOXB4 downstream program by identifying Hemgn as a direct target that partially mediates myeloid expansion.","evidence":"Inducible HOXB4-ER, expression microarray, ChIP at Hemgn promoter, and Hemgn gain/loss-of-function colony assays","pmids":["20393131"],"confidence":"High","gaps":["Hemgn only partially recapitulates HOXB4 effect","Other targets needed for full activity"]},{"year":2010,"claim":"Uncovered a non-transcriptional role for HOXB4 as part of an E3 ligase, showing it assembles RDCOXB4 (Roc1-Ddb1-Cul4a) to degrade Geminin and promote proliferation.","evidence":"Co-IP of the Roc1-Ddb1-Cul4a complex, ubiquitination assays, and Geminin gain/loss-of-function with competitive repopulation","pmids":["21098278"],"confidence":"Medium","gaps":["Single lab","Structural basis of complex assembly unknown","Relation to transcriptional activity unclear"]},{"year":2011,"claim":"Mapped the genome-wide direct target network, identifying Runx1, Scl/Tal1, Gata2 and Gfi1 as direct targets and showing context-dependent activation versus repression.","evidence":"ChIP-seq and genome-wide expression profiling in ES-derived HSPCs with inducible HoxB4","pmids":["21343615","22438249"],"confidence":"Medium","gaps":["Per-target functional validation limited","Determinants of activation versus repression unresolved"]},{"year":2013,"claim":"Established post-translational and chromatin-level layers of regulation: CUL4 degrades HOXB4 via a conserved homeodomain degron, while USF1 recruits hSET1A to deposit activating H3K4me3.","evidence":"Co-IP with CUL4, degron mapping, degradation-resistant variants in human HSC transplants, and ChIP for H3K4me3/USF1/hSET1A in ESC differentiation","pmids":["23520338","23754954"],"confidence":"Medium","gaps":["Degron degradation signal and E3 substrate-recognition details incomplete","Single labs"]},{"year":2014,"claim":"Defined how HOXB4 expansion is decoupled from leukemia, showing repression of Prdm16 prevents transformation and placing HoxB4 in a shared STAT3 self-renewal pathway.","evidence":"Expression profiling and sPrdm16 co-expression leukemia model; STAT3 co-transduction/inhibition with phospho-STAT3 and transcriptome overlap","pmids":["25082879","24446131"],"confidence":"Medium","gaps":["Mechanism of STAT3 ligand-independent phosphorylation unknown","Direct versus indirect Prdm16 repression not fully resolved"]},{"year":2016,"claim":"Identified the structural basis restraining oncogenicity, showing a unique conserved N-terminal proline-rich domain limits stem cell amplification.","evidence":"Domain deletion and reciprocal HOXB4/HOXA9 domain-swap mutagenesis with in vivo leukemia monitoring","pmids":["27827825","18357342"],"confidence":"High","gaps":["Molecular partners of the proline-rich domain unknown","Mechanism by which it restrains amplification undefined"]},{"year":2021,"claim":"Extended HOXB4 function to non-hematopoietic cancer contexts, showing direct transcriptional regulation of β-catenin, DHDDS, and additional targets.","evidence":"ChIP/reporter binding assays, gain/loss-of-function, rescue, and xenografts in cervical and ovarian cancer cells","pmids":["33479226","32178630","31768017"],"confidence":"Medium","gaps":["Context determinants of repression versus activation unclear","Single labs per tumor type"]},{"year":null,"claim":"The integration of HOXB4's transcriptional, E3-ligase, and translational/post-translational regulatory layers into a unified model of how the HSC expansion ceiling is enforced remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["The non-cell-autonomous mechanism capping HSC expansion is unidentified","How direct DNA targets, Geminin degradation, and STAT3 signaling converge mechanistically is unknown","Physiological relevance of Prep1-4EHP and miR-23a/IGF2BP1 mRNA regulation in HSCs untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,7,20,29,36,37]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[7,18,20,29]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[22]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[14,20,29]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,20,29]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[10,11,40]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[21,22]}],"complexes":["RDCOXB4 (Roc1-Ddb1-Cul4a E3 ligase)"],"partners":["PBX1","USF1","USF2","NFYA","CUL4","GEMININ","PREP1","STAT3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P17483","full_name":"Homeobox protein Hox-B4","aliases":["Homeobox protein Hox-2.6","Homeobox protein Hox-2F"],"length_aa":251,"mass_kda":27.6,"function":"Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P17483/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HOXB4","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HOXB4","total_profiled":1310},"omim":[{"mim_id":"610173","title":"MICRO RNA 10A; MIR10A","url":"https://www.omim.org/entry/610173"},{"mim_id":"608985","title":"RING FINGER PROTEIN 2; RNF2","url":"https://www.omim.org/entry/608985"},{"mim_id":"606359","title":"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A","url":"https://www.omim.org/entry/606359"},{"mim_id":"603816","title":"AXIS INHIBITOR 1; AXIN1","url":"https://www.omim.org/entry/603816"},{"mim_id":"603408","title":"FRIZZLED CLASS RECEPTOR 1; FZD1","url":"https://www.omim.org/entry/603408"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Centrosome","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HOXB4"},"hgnc":{"alias_symbol":[],"prev_symbol":["HOX2","HOX2F"]},"alphafold":{"accession":"P17483","domains":[{"cath_id":"1.10.10.60","chopping":"170-223","consensus_level":"medium","plddt":96.2778,"start":170,"end":223}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P17483","model_url":"https://alphafold.ebi.ac.uk/files/AF-P17483-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P17483-F1-predicted_aligned_error_v6.png","plddt_mean":66.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HOXB4","jax_strain_url":"https://www.jax.org/strain/search?query=HOXB4"},"sequence":{"accession":"P17483","fasta_url":"https://rest.uniprot.org/uniprotkb/P17483.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P17483/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P17483"}},"corpus_meta":[{"pmid":"11955444","id":"PMC_11955444","title":"HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11955444","citation_count":601,"is_preprint":false},{"pmid":"11955445","id":"PMC_11955445","title":"HOXB4-induced expansion of adult hematopoietic stem cells ex vivo.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11955445","citation_count":520,"is_preprint":false},{"pmid":"7622039","id":"PMC_7622039","title":"Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7622039","citation_count":460,"is_preprint":false},{"pmid":"15883170","id":"PMC_15883170","title":"Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15883170","citation_count":232,"is_preprint":false},{"pmid":"14578881","id":"PMC_14578881","title":"In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein.","date":"2003","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14578881","citation_count":230,"is_preprint":false},{"pmid":"9697850","id":"PMC_9697850","title":"Initiation of rhombomeric Hoxb4 expression requires induction by somites and a retinoid pathway.","date":"1998","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/9697850","citation_count":226,"is_preprint":false},{"pmid":"14578882","id":"PMC_14578882","title":"Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein.","date":"2003","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14578882","citation_count":214,"is_preprint":false},{"pmid":"7628700","id":"PMC_7628700","title":"Compound mutants for the paralogous hoxa-4, hoxb-4, and hoxd-4 genes show more complete homeotic transformations and a dose-dependent increase in the number of vertebrae transformed.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7628700","citation_count":206,"is_preprint":false},{"pmid":"11532354","id":"PMC_11532354","title":"HOXB4 overexpression mediates very rapid stem cell regeneration and competitive hematopoietic repopulation.","date":"2001","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/11532354","citation_count":168,"is_preprint":false},{"pmid":"9012503","id":"PMC_9012503","title":"Targeted disruption of the Hoxb-2 locus in mice interferes with expression of Hoxb-1 and Hoxb-4.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9012503","citation_count":120,"is_preprint":false},{"pmid":"31768017","id":"PMC_31768017","title":"RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1.","date":"2019","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/31768017","citation_count":118,"is_preprint":false},{"pmid":"12406897","id":"PMC_12406897","title":"High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12406897","citation_count":118,"is_preprint":false},{"pmid":"10515864","id":"PMC_10515864","title":"Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10515864","citation_count":113,"is_preprint":false},{"pmid":"14962901","id":"PMC_14962901","title":"Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/14962901","citation_count":101,"is_preprint":false},{"pmid":"12130496","id":"PMC_12130496","title":"Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12130496","citation_count":96,"is_preprint":false},{"pmid":"8639890","id":"PMC_8639890","title":"Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8639890","citation_count":94,"is_preprint":false},{"pmid":"12748289","id":"PMC_12748289","title":"Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12748289","citation_count":94,"is_preprint":false},{"pmid":"18357342","id":"PMC_18357342","title":"High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector.","date":"2008","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/18357342","citation_count":91,"is_preprint":false},{"pmid":"12855555","id":"PMC_12855555","title":"Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12855555","citation_count":84,"is_preprint":false},{"pmid":"17940039","id":"PMC_17940039","title":"HOXB4's road map to stem cell expansion.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17940039","citation_count":77,"is_preprint":false},{"pmid":"9692548","id":"PMC_9692548","title":"Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9692548","citation_count":72,"is_preprint":false},{"pmid":"16093308","id":"PMC_16093308","title":"HOXB4 enforces equivalent fates of ES-cell-derived and adult hematopoietic cells.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16093308","citation_count":71,"is_preprint":false},{"pmid":"12705858","id":"PMC_12705858","title":"The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential.","date":"2003","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12705858","citation_count":65,"is_preprint":false},{"pmid":"12791656","id":"PMC_12791656","title":"NF-Y cooperates with USF1/2 to induce the hematopoietic expression of HOXB4.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12791656","citation_count":63,"is_preprint":false},{"pmid":"16410392","id":"PMC_16410392","title":"HOXB4 overexpression promotes hematopoietic development by human embryonic stem cells.","date":"2006","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/16410392","citation_count":59,"is_preprint":false},{"pmid":"11420646","id":"PMC_11420646","title":"Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy.","date":"2001","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/11420646","citation_count":57,"is_preprint":false},{"pmid":"23754954","id":"PMC_23754954","title":"USF1 and hSET1A mediated epigenetic modifications regulate lineage differentiation and HoxB4 transcription.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23754954","citation_count":52,"is_preprint":false},{"pmid":"15226173","id":"PMC_15226173","title":"Molecular interactions involved in HOXB4-induced activation of HSC self-renewal.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15226173","citation_count":52,"is_preprint":false},{"pmid":"8555111","id":"PMC_8555111","title":"Comparative analysis of chicken Hoxb-4 regulation in transgenic mice.","date":"1995","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/8555111","citation_count":51,"is_preprint":false},{"pmid":"17253940","id":"PMC_17253940","title":"Stem cell c-KIT and HOXB4 genes: critical roles and mechanisms in self-renewal, proliferation, and differentiation.","date":"2006","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/17253940","citation_count":47,"is_preprint":false},{"pmid":"12135926","id":"PMC_12135926","title":"Spatially specific expression of Hoxb4 is dependent on the ubiquitous transcription factor NFY.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12135926","citation_count":46,"is_preprint":false},{"pmid":"26202933","id":"PMC_26202933","title":"Activation of OCT4 enhances ex vivo expansion of human cord blood hematopoietic stem and progenitor cells by regulating HOXB4 expression.","date":"2015","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/26202933","citation_count":46,"is_preprint":false},{"pmid":"21343615","id":"PMC_21343615","title":"Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21343615","citation_count":44,"is_preprint":false},{"pmid":"22438249","id":"PMC_22438249","title":"Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22438249","citation_count":43,"is_preprint":false},{"pmid":"18056836","id":"PMC_18056836","title":"Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18056836","citation_count":43,"is_preprint":false},{"pmid":"19365557","id":"PMC_19365557","title":"Cytoplasmic Prep1 interacts with 4EHP inhibiting Hoxb4 translation.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19365557","citation_count":41,"is_preprint":false},{"pmid":"12736215","id":"PMC_12736215","title":"Multiple levels of transcriptional and post-transcriptional regulation are required to define the domain of Hoxb4 expression.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12736215","citation_count":41,"is_preprint":false},{"pmid":"10085075","id":"PMC_10085075","title":"c-myc intron element-binding proteins are required for 1, 25-dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10085075","citation_count":41,"is_preprint":false},{"pmid":"11085749","id":"PMC_11085749","title":"Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2.","date":"2000","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11085749","citation_count":39,"is_preprint":false},{"pmid":"11518511","id":"PMC_11518511","title":"Hoxb2 and hoxb4 act together to specify ventral body wall formation.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11518511","citation_count":38,"is_preprint":false},{"pmid":"27779650","id":"PMC_27779650","title":"HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.","date":"2016","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27779650","citation_count":37,"is_preprint":false},{"pmid":"16637742","id":"PMC_16637742","title":"Differential effects of HOXB4 on nonhuman primate short- and long-term repopulating cells.","date":"2006","source":"PLoS medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16637742","citation_count":37,"is_preprint":false},{"pmid":"20404135","id":"PMC_20404135","title":"Downstream targets of HOXB4 in a cell line model of primitive hematopoietic progenitor cells.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20404135","citation_count":35,"is_preprint":false},{"pmid":"33479226","id":"PMC_33479226","title":"HOXB4 inhibits the proliferation and tumorigenesis of cervical cancer cells by downregulating the activity of Wnt/β-catenin signaling pathway.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33479226","citation_count":34,"is_preprint":false},{"pmid":"20393131","id":"PMC_20393131","title":"Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20393131","citation_count":34,"is_preprint":false},{"pmid":"14529835","id":"PMC_14529835","title":"Enforced adenoviral vector-mediated expression of HOXB4 in human umbilical cord blood CD34+ cells promotes myeloid differentiation but not proliferation.","date":"2003","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/14529835","citation_count":33,"is_preprint":false},{"pmid":"17761289","id":"PMC_17761289","title":"Hoxa9/hoxb3/hoxb4 compound null mice display severe hematopoietic defects.","date":"2007","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/17761289","citation_count":32,"is_preprint":false},{"pmid":"16210402","id":"PMC_16210402","title":"HOXB4-induced self-renewal of hematopoietic stem cells is significantly enhanced by p21 deficiency.","date":"2005","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/16210402","citation_count":31,"is_preprint":false},{"pmid":"23520338","id":"PMC_23520338","title":"Improved ex vivo expansion of adult hematopoietic stem cells by overcoming CUL4-mediated degradation of HOXB4.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23520338","citation_count":31,"is_preprint":false},{"pmid":"7969151","id":"PMC_7969151","title":"Multiple positive and negative regulatory elements in the promoter of the mouse homeobox gene Hoxb-4.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7969151","citation_count":30,"is_preprint":false},{"pmid":"21098278","id":"PMC_21098278","title":"Hoxb4 transduction down-regulates Geminin protein, providing hematopoietic stem and progenitor cells with proliferation potential.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21098278","citation_count":29,"is_preprint":false},{"pmid":"11984874","id":"PMC_11984874","title":"HOXB4 homeodomain protein is expressed in developing epidermis and skin disorders and modulates keratinocyte proliferation.","date":"2002","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/11984874","citation_count":29,"is_preprint":false},{"pmid":"21278354","id":"PMC_21278354","title":"Hoxb4-YFP reporter mouse model: a novel tool for tracking HSC development and studying the role of Hoxb4 in hematopoiesis.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21278354","citation_count":27,"is_preprint":false},{"pmid":"20921340","id":"PMC_20921340","title":"Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20921340","citation_count":26,"is_preprint":false},{"pmid":"22084016","id":"PMC_22084016","title":"HOXB4 can enhance the differentiation of embryonic stem cells by modulating the hematopoietic niche.","date":"2012","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/22084016","citation_count":25,"is_preprint":false},{"pmid":"22298821","id":"PMC_22298821","title":"HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4.","date":"2012","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/22298821","citation_count":25,"is_preprint":false},{"pmid":"17510218","id":"PMC_17510218","title":"Effects of HOXB4 overexpression on ex vivo expansion and immortalization of hematopoietic cells from different species.","date":"2007","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/17510218","citation_count":25,"is_preprint":false},{"pmid":"15509504","id":"PMC_15509504","title":"Enhanced in vivo selection of bone marrow cells by retroviral-mediated coexpression of mutant O6-methylguanine-DNA-methyltransferase and HOXB4.","date":"2004","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/15509504","citation_count":25,"is_preprint":false},{"pmid":"15958692","id":"PMC_15958692","title":"Control of self-renewal and differentiation of hematopoietic stem cells: HOXB4 on the threshold.","date":"2005","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15958692","citation_count":24,"is_preprint":false},{"pmid":"18511880","id":"PMC_18511880","title":"Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells.","date":"2008","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/18511880","citation_count":24,"is_preprint":false},{"pmid":"18617691","id":"PMC_18617691","title":"Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation.","date":"2008","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/18617691","citation_count":23,"is_preprint":false},{"pmid":"25082879","id":"PMC_25082879","title":"Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25082879","citation_count":22,"is_preprint":false},{"pmid":"17784829","id":"PMC_17784829","title":"Recombinant HoxB4 fusion proteins enhance hematopoietic differentiation of human embryonic stem cells.","date":"2007","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/17784829","citation_count":22,"is_preprint":false},{"pmid":"19828634","id":"PMC_19828634","title":"HOXB4-transduced embryonic stem cell-derived Lin-c-kit+ and Lin-Sca-1+ hematopoietic progenitors express H60 and are targeted by NK cells.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19828634","citation_count":22,"is_preprint":false},{"pmid":"29660518","id":"PMC_29660518","title":"HOXB4 knockdown enhances the cytotoxic effect of paclitaxel and cisplatin by downregulating ABC transporters in ovarian cancer cells.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29660518","citation_count":21,"is_preprint":false},{"pmid":"34568444","id":"PMC_34568444","title":"AKR1C3 and Its Transcription Factor HOXB4 Are Promising Diagnostic Biomarkers for Acute Myocardial Infarction.","date":"2021","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34568444","citation_count":20,"is_preprint":false},{"pmid":"27352929","id":"PMC_27352929","title":"Enforced Expression of HOXB4 in Human Embryonic Stem Cells Enhances the Production of Hematopoietic Progenitors but Has No Effect on the Maturation of Red Blood Cells.","date":"2016","source":"Stem cells translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27352929","citation_count":20,"is_preprint":false},{"pmid":"19270262","id":"PMC_19270262","title":"Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19270262","citation_count":20,"is_preprint":false},{"pmid":"12701098","id":"PMC_12701098","title":"TALE class homeodomain gene Irx5 is an immediate downstream target for Hoxb4 transcriptional regulation.","date":"2003","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/12701098","citation_count":20,"is_preprint":false},{"pmid":"29456178","id":"PMC_29456178","title":"HOXB4 Promotes Hemogenic Endothelium Formation without Perturbing Endothelial Cell Development.","date":"2018","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29456178","citation_count":18,"is_preprint":false},{"pmid":"16357528","id":"PMC_16357528","title":"HOXB4 inhibits cell growth in a dose-dependent manner and sensitizes cells towards extrinsic cues.","date":"2006","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/16357528","citation_count":18,"is_preprint":false},{"pmid":"11250656","id":"PMC_11250656","title":"Antisense knockout of HOXB4 blocks 1,25-dihydroxyvitamin D3 inhibition of c-myc expression.","date":"2001","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11250656","citation_count":18,"is_preprint":false},{"pmid":"22761810","id":"PMC_22761810","title":"The HOXB4 homeoprotein promotes the ex vivo enrichment of functional human embryonic stem cell-derived NK cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22761810","citation_count":18,"is_preprint":false},{"pmid":"14697356","id":"PMC_14697356","title":"FLASH, a component of the FAS-CAPSASE8 apoptotic pathway, is directly regulated by Hoxb4 in the notochord.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/14697356","citation_count":18,"is_preprint":false},{"pmid":"18553509","id":"PMC_18553509","title":"Unique spatial and cellular expression patterns of Hoxa5, Hoxb4, and Hoxb6 proteins in normal developing murine lung are modified in pulmonary hypoplasia.","date":"2008","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/18553509","citation_count":17,"is_preprint":false},{"pmid":"24446131","id":"PMC_24446131","title":"Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: a model of molecular convergence for stemness.","date":"2014","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/24446131","citation_count":17,"is_preprint":false},{"pmid":"22267295","id":"PMC_22267295","title":"Mechanism of action of HOXB4 on the hematopoietic differentiation of embryonic stem cells.","date":"2012","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/22267295","citation_count":16,"is_preprint":false},{"pmid":"23630040","id":"PMC_23630040","title":"Identification of the transcription factor HOXB4 as a novel target of miR-23a.","date":"2013","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23630040","citation_count":16,"is_preprint":false},{"pmid":"10373014","id":"PMC_10373014","title":"RARbeta mediates the response of Hoxd4 and Hoxb4 to exogenous retinoic acid.","date":"1999","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10373014","citation_count":16,"is_preprint":false},{"pmid":"19104426","id":"PMC_19104426","title":"HOXB4 but not BMP4 confers self-renewal properties to ES-derived hematopoietic progenitor cells.","date":"2008","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/19104426","citation_count":15,"is_preprint":false},{"pmid":"17962697","id":"PMC_17962697","title":"The HOXB4 homeoprotein differentially promotes ex vivo expansion of early human lymphoid progenitors.","date":"2007","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/17962697","citation_count":15,"is_preprint":false},{"pmid":"22000550","id":"PMC_22000550","title":"Promotion of hematopoietic differentiation from mouse induced pluripotent stem cells by transient HoxB4 transduction.","date":"2011","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/22000550","citation_count":15,"is_preprint":false},{"pmid":"15580301","id":"PMC_15580301","title":"HOXB4 confers a constant rate of in vitro proliferation to transduced bone marrow cells.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15580301","citation_count":14,"is_preprint":false},{"pmid":"20875838","id":"PMC_20875838","title":"Ex vivo expansion of human HSCs with Sendai virus vector expressing HoxB4 assessed by sheep in utero transplantation.","date":"2010","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/20875838","citation_count":14,"is_preprint":false},{"pmid":"20184433","id":"PMC_20184433","title":"Induction of hematopoietic differentiation of mouse embryonic stem cells by an AGM-derived stromal cell line is not further enhanced by overexpression of HOXB4.","date":"2010","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/20184433","citation_count":14,"is_preprint":false},{"pmid":"27827825","id":"PMC_27827825","title":"Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/27827825","citation_count":13,"is_preprint":false},{"pmid":"19120358","id":"PMC_19120358","title":"Expansion of haematopoietic stem cells from normal donors and bone marrow failure patients by recombinant hoxb4.","date":"2008","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19120358","citation_count":13,"is_preprint":false},{"pmid":"20424597","id":"PMC_20424597","title":"Successful treatment of metachromatic leukodystrophy using bone marrow transplantation of HoxB4 overexpressing cells.","date":"2010","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20424597","citation_count":13,"is_preprint":false},{"pmid":"32178630","id":"PMC_32178630","title":"HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.","date":"2020","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32178630","citation_count":12,"is_preprint":false},{"pmid":"30419846","id":"PMC_30419846","title":"MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30419846","citation_count":12,"is_preprint":false},{"pmid":"20625746","id":"PMC_20625746","title":"HoxB2, HoxB4 and Alx4 genes are downregulated in the cadmium-induced omphalocele in the chick model.","date":"2010","source":"Pediatric surgery international","url":"https://pubmed.ncbi.nlm.nih.gov/20625746","citation_count":12,"is_preprint":false},{"pmid":"25628780","id":"PMC_25628780","title":"Co-transplantation with mesenchymal stem cells expressing a SDF-1/HOXB4 fusion protein markedly improves hematopoietic stem cell engraftment and hematogenesis in irradiated mice.","date":"2014","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/25628780","citation_count":12,"is_preprint":false},{"pmid":"34349541","id":"PMC_34349541","title":"Overexpression of HOXB4 Promotes Protection of Bone Marrow Mesenchymal Stem Cells Against Lipopolysaccharide-Induced Acute Lung Injury Partially Through the Activation of Wnt/β-Catenin Signaling.","date":"2021","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/34349541","citation_count":12,"is_preprint":false},{"pmid":"15206819","id":"PMC_15206819","title":"Hoxb4 in oligodendrogenesis.","date":"2004","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/15206819","citation_count":11,"is_preprint":false},{"pmid":"29039487","id":"PMC_29039487","title":"Functional analysis of HOXA10 and HOXB4 in human medulloblastoma cell lines.","date":"2017","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29039487","citation_count":11,"is_preprint":false},{"pmid":"19022763","id":"PMC_19022763","title":"Complementary and independent function for Hoxb4 and Bmi1 in HSC activity.","date":"2008","source":"Cold Spring Harbor symposia on quantitative biology","url":"https://pubmed.ncbi.nlm.nih.gov/19022763","citation_count":11,"is_preprint":false},{"pmid":"22522741","id":"PMC_22522741","title":"The functional duality of HoxB4 in hematopoietic reconstituting cells.","date":"2012","source":"Cytometry. Part A : the journal of the International Society for Analytical Cytology","url":"https://pubmed.ncbi.nlm.nih.gov/22522741","citation_count":10,"is_preprint":false},{"pmid":"38182548","id":"PMC_38182548","title":"LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc.","date":"2024","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/38182548","citation_count":9,"is_preprint":false},{"pmid":"28969513","id":"PMC_28969513","title":"HOXB4 Immunoreactivity in Endometrial Tissues From Women With or Without Endometriosis.","date":"2017","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/28969513","citation_count":9,"is_preprint":false},{"pmid":"32795499","id":"PMC_32795499","title":"Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.","date":"2020","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/32795499","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50629,"output_tokens":11182,"usd":0.159808,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21821,"output_tokens":5730,"usd":0.126177,"stage2_stop_reason":"end_turn"},"total_usd":0.285985,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Retroviral overexpression of HOXB4 in murine bone marrow cells selectively expands the most primitive hematopoietic stem cell (HSC) compartment, resulting in ~50-fold higher numbers of transplantable totipotent HSCs in primary and secondary recipients, without perturbing lineage differentiation or causing overt pathology. HOXB4 functions as a transcription factor regulating HSC self-renewal and proliferative potential.\",\n      \"method\": \"Retroviral gene transfer into murine bone marrow, serial transplantation, limit dilution assay for long-term competitive repopulating cells, in vitro colony assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean gain-of-function in primary HSCs with defined in vitro and in vivo phenotypic readouts, replicated across multiple independent labs in subsequent studies\",\n      \"pmids\": [\"7622039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HOXB4 expression in primitive yolk-sac or embryonic stem (ES) cell-derived progenitors, combined with culture on hematopoietic stroma, induces a switch to the definitive HSC phenotype capable of long-term multilineage engraftment in lethally irradiated adults, demonstrating HOXB4 confers definitive lymphoid-myeloid engraftment potential on primitive progenitors.\",\n      \"method\": \"Retroviral HOXB4 overexpression in ES-cell and yolk-sac progenitors, stromal co-culture, transplantation into lethally irradiated mice, multilineage reconstitution assay in primary and secondary recipients\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct in vivo engraftment assay with primary and secondary recipients, replicated by multiple independent groups\",\n      \"pmids\": [\"11955444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HOXB4 overexpression in murine bone marrow enables over 1000-fold higher HSC levels relative to controls and a 40-fold net HSC increase ex vivo, with HSCs retaining full lympho-myeloid repopulating potential, establishing HOXB4 as a potent positive regulator of HSC self-renewal ex vivo.\",\n      \"method\": \"Retroviral HOXB4 transduction of murine bone marrow, 10-14 day expansion culture, limit dilution competitive repopulating unit (CRU) assay, transplantation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quantitative CRU assay with transplantation, independently confirmed by multiple labs\",\n      \"pmids\": [\"11955445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Cellular transformation and proliferation induced by HOXB4 (and HOXB3) in Rat-1 fibroblasts requires cooperation with PBX1; the transforming capacity depends on the conserved tetrapeptide (HOX-PBX interaction domain) and the homeodomain (DNA-binding domain). Modulating PBX1 levels directly modulates HOXB4-induced transformation.\",\n      \"method\": \"Rat-1 fibroblast transformation assay, overexpression and knockdown of PBX1, HOXB4 point mutants lacking tetrapeptide or homeodomain function\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis of functional domains combined with cellular transformation assay and PBX1 modulation, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"9692548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Recombinant TAT-HOXB4 protein (carrying the HIV-TAT protein transduction domain) directly transduces into HSCs and expands murine HSCs ~4–6 fold ex vivo, comparable to retroviral HOXB4, demonstrating that HOXB4 protein itself (not just gene expression) is sufficient to drive HSC expansion and that the protein passively translocates across cell membranes.\",\n      \"method\": \"Recombinant protein production, protein transduction into murine bone marrow HSCs, competitive repopulation assay in transplanted mice\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein delivery (circumventing gene transfer) with in vivo CRU assay, replicated by independent lab (PMID:14578882)\",\n      \"pmids\": [\"14578881\", \"14578882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Human HSCs (LTC-ICs and NOD-SCID repopulating cells) can be expanded >20-fold (LTC-IC) and >2.5-fold (SRC) by HOXB4 protein delivered via stromal cells engineered to secrete it, confirming the membrane-translocating property of the HOXB4 homeoprotein and its ability to expand human HSCs without genetic modification.\",\n      \"method\": \"Stromal cells engineered to secrete HOXB4, co-culture with human HSCs, LTC-IC assay, NOD-SCID repopulation assay\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein delivery to human HSCs with in vivo repopulation assay, independent replication of TAT-HOXB4 approach\",\n      \"pmids\": [\"14578882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HOXB4-induced HSC expansion in vivo is limited by the availability of PBX1: knockdown of PBX1 in HOXB4-overexpressing HSCs generates 'ultra-competitive' HSCs that are >20-fold more competitive than HOXB4-alone cells, yet still do not exceed normal HSC pool size in vivo, suggesting a non-cell-autonomous mechanism limits expansion.\",\n      \"method\": \"Retroviral overexpression of HOXB4 combined with PBX1 shRNA knockdown in murine bone marrow, competitive transplantation, multilineage reconstitution\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis via combined gain-of-function (HOXB4) and loss-of-function (PBX1 KD) with in vivo competitive repopulation, single lab\",\n      \"pmids\": [\"12705858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HOXB4-induced HSC expansion requires direct DNA binding by HOXB4: a DNA-binding-incompetent HOXB4 mutant (HOXB4-A) fails to enhance HSC proliferation in vitro or expansion in vivo. Conversely, a mutant lacking HOX-PBX cooperative DNA binding (HOXB4-W→G) retains and even enhances in vitro proliferation and in vivo expansion, demonstrating that HOXB4 acts through direct DNA binding independent of HOX-PBX cooperative interaction.\",\n      \"method\": \"Retroviral overexpression of HOXB4 point mutants (DNA-binding-incompetent and PBX-interaction-deficient) in murine bone marrow, in vitro proliferation assay, in vivo competitive repopulation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — active-site mutagenesis with defined functional readouts in primary cells and in vivo, single lab but two orthogonal mutant analyses\",\n      \"pmids\": [\"15226173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HOXB4 transcription in human hematopoietic cells is activated through an E-box binding site (HXRE-2) in its promoter by USF-1 and USF-2 transcription factors acting via the MAP kinase pathway; USF-2 was identified by yeast one-hybrid screen of bone marrow library. MITF binds the same site but does not activate the promoter.\",\n      \"method\": \"Promoter deletion/mutation analysis, yeast one-hybrid screen, EMSA, co-transfection luciferase assays in K562 and CD34+ cells, MAP kinase pathway inhibition\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple complementary approaches (yeast one-hybrid, EMSA, mutagenesis, co-transfection) in primary and cell line contexts\",\n      \"pmids\": [\"11085749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The trimeric NF-Y complex binds the HxRE-1 site of the HOXB4 promoter, activates HOXB4 transcription in hematopoietic cells, and physically interacts with USF1/2 on the HOXB4 promoter; NF-Y occupancy on the HOXB4 promoter is reduced during granulocytic differentiation as NF-Ya levels decline, suggesting NF-Y is a developmentally regulated inducer of HOXB4.\",\n      \"method\": \"Promoter analysis, EMSA, ChIP assay, co-transfection with dominant-negative NF-Y subunits, co-immunoprecipitation of NF-Y/USF1/2 complex\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — ChIP in primary cells + EMSA + co-IP + functional promoter assays, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"12791656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hoxb4 rhombomeric expression in the vertebrate hindbrain is initiated by transient signaling from paraxial mesoderm (somites) through a retinoid pathway requiring retinoic acid receptor (RAR) function within the neural plate; a retinoic acid response element (RARE) within a prerhombomeric enhancer of Hoxb4 is essential for this neural response and interprets positional information for setting the anterior boundary of expression.\",\n      \"method\": \"Chick/mouse embryo tissue transposition, RAR inhibition in neural plate, enhancer-reporter transgenic mice, mutagenesis of RA response element\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — enhancer mutagenesis in transgenic mice combined with embryological tissue manipulations and RAR pathway interference\",\n      \"pmids\": [\"9697850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Compound mutants for paralogous group 4 Hox genes (hoxa-4, hoxb-4, hoxd-4) show more complete and dose-dependent homeotic transformations of cervical vertebrae than single mutants, demonstrating functional redundancy among paralogous genes and revealing a larger anteroposterior domain of requirement than single mutants indicate.\",\n      \"method\": \"Targeted gene disruption in mice (gene targeting), generation of double and triple Hox group 4 compound mutants, skeletal phenotype analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via compound null mutants, clear dose-dependent phenotypic series\",\n      \"pmids\": [\"7628700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HOXB4-overexpressing HSCs regenerate to fully reconstitute the HSC compartment post-transplantation (14-fold more HSCs than control transplants) but do not expand above normal HSC levels found in unmanipulated mice, indicating that HOXB4 overexpression does not override homeostatic mechanisms controlling HSC pool size.\",\n      \"method\": \"Murine bone marrow transplantation with HOXB4-retroviral transduced cells, HSC quantification by competitive repopulation over 12 months\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — long-term in vivo quantification of HSC pool size with multiple cohorts, establishes a ceiling on HOXB4-mediated expansion\",\n      \"pmids\": [\"10515864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Hematopoietic expression of HOXB4 is regulated by thrombopoietin (TPO) via the p38 MAP kinase pathway, which induces upstream stimulating factor-1 (USF-1), which in turn activates HOXB4 transcription; TPO-null mice have 2–5-fold lower Hoxb4 expression in candidate HSCs.\",\n      \"method\": \"TPO stimulation of primitive hematopoietic cell lines, p38 MAPK pharmacological inhibition, comparison of tpo-/- and control mouse HSC Hoxb4 mRNA levels, USF-1 activation assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cytokine-to-kinase-to-transcription factor pathway established by pharmacological inhibition and genetic null model, single lab\",\n      \"pmids\": [\"12855555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cytoplasmic Prep1 interacts with 4EHP (eukaryotic translation initiation factor 4E homolog protein) in mouse oocytes and together they repress translation of Hoxb4 mRNA by Prep1 binding to the Hoxb4 3'UTR; a functional 4EHP-binding motif in Prep1 is required for this repression. Hoxb4 is overproduced in hypomorphic Prep1 oocytes, establishing Prep1-4EHP as a translational repressor of Hoxb4.\",\n      \"method\": \"Confocal microscopy/co-localization, co-immunoprecipitation, pulldown, site-directed mutagenesis of 4EHP-binding motif, in vitro translation assay with luciferase-Hoxb4-3'UTR reporter, RNA EMSA, immunohistochemistry in Prep1 hypomorphic mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (co-IP, pulldown, mutagenesis, in vitro translation, EMSA) in single study establishing a translational regulatory mechanism\",\n      \"pmids\": [\"19365557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Multiple regulatory elements control Hoxb4 mesodermal expression: an intronic enhancer (region C) is sufficient for temporal activation and setting the anterior somitic boundary (somite 6/7), but the Hoxb4 promoter is required to maintain expression beyond E8.5; sequences in the 3'UTR (region B) are necessary specifically to maintain expression in somite 7 from E9.0 onward. Post-transcriptional regulation including transcript stability and selective protein translation/degradation also restricts the Hoxb4 expression domain.\",\n      \"method\": \"Transgenic mouse reporter analysis with defined regulatory element deletions, in situ hybridization, developmental time-course analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic dissection of regulatory elements in transgenic mice with multiple constructs, single lab\",\n      \"pmids\": [\"12736215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"An intron enhancer of mouse Hoxb4 requires binding by NFY (at an NFY/YY1 overlapping motif) for its activity in establishing the anterior boundary of mesodermal expression; specific mutations abolishing NFY binding eliminate enhancer activity. The same NFY/YY1 motif is present in the Hoxb4 promoter, suggesting relative NFY vs YY1 occupancy as a mechanism for balancing activation and repression.\",\n      \"method\": \"Heterologous promoter-reporter assays, site-directed mutagenesis of NFY and YY1 binding sites, transgenic mouse assay for anterior boundary of mesodermal expression\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis in transgenic mice with functional boundary readout, single lab\",\n      \"pmids\": [\"12135926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The Hoxb-4 promoter contains multiple positive and negative regulatory elements: two cell-type-specific negative regulatory elements (regions a and d), an additional negative element (region b), and a positive element binding a novel factor HoxTF at sequence GCCATTGG that is essential for efficient Hoxb-4 expression; two 12-bp initiator elements flank each of the two transcription start sites (P1 and P2).\",\n      \"method\": \"Nuclease S1 and primer extension mapping of transcription start sites, detailed promoter mutagenesis with CAT reporter assays in multiple cell lines\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic promoter mutagenesis with reporter assays, single lab, in vitro context\",\n      \"pmids\": [\"7969151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HOXB4 is identified as a 1,25-dihydroxyvitamin D3-inducible protein that binds to the MIE1 site in c-myc intron 1 and participates in blocking c-myc transcriptional elongation during HL-60 monocytic differentiation; the MIE1 and MIE2/MIE3 sites are required for D3-mediated suppression of c-myc, and this binding activity requires PKCβ signaling.\",\n      \"method\": \"CAT reporter assays with c-myc promoter constructs containing deletions/mutations of MIE sites, gel-shift/EMSA, protein identification of MIE1-binding protein as HOXB4, PKCβ antisense and pharmacological inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA protein identification + functional reporter assays + PKC inhibition, single lab, HL-60 cell system\",\n      \"pmids\": [\"10085075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Antisense knockdown of HOXB4 partially blocks 1,25-dihydroxyvitamin D3-mediated suppression of c-myc and inhibits HL-60 differentiation, establishing that endogenous HOXB4 is functionally required downstream of vitamin D3 signaling to suppress c-myc transcription elongation.\",\n      \"method\": \"Phosphorothioate antisense oligonucleotide knockdown of HOXB4, c-myc protein level measurement, HL-60 differentiation assays (NBT and non-specific esterase)\",\n      \"journal\": \"The Journal of endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function antisense with defined molecular and cellular phenotype readouts, corroborates gain-of-function data from companion paper\",\n      \"pmids\": [\"11250656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hemogen (Hemgn), a hematopoietic-specific nuclear protein, is a direct transcriptional target of HOXB4: HOXB4 binds to the Hemgn promoter region both ex vivo and in vivo (ChIP). Overexpression of Hemgn partially recapitulates HOXB4-mediated myeloid progenitor expansion, and shRNA knockdown of Hemgn reduces HOXB4-mediated expansion.\",\n      \"method\": \"Tamoxifen-inducible HOXB4-ER(T2) system in lineage-negative murine bone marrow, expression microarrays, ChIP assay for HOXB4 binding to Hemgn promoter, Hemgn overexpression and shRNA knockdown with myeloid colony assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct target validated by ChIP + inducible system + gain-of-function + loss-of-function, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"20393131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CUL4 ubiquitin ligase mediates post-translational degradation of HOXB4 protein through a conserved degradation signal sequence (degron) in the homeodomain, giving HOXB4 a short protein half-life (~1 hour). A CUL4-resistant (degradation-resistant) HOXB4 mutant has enhanced activity in expanding myeloid progenitors and better maintains human HSCs in a primitive state in vitro and in vivo. This degron is conserved in additional HOX paralogues.\",\n      \"method\": \"Co-immunoprecipitation of HOXB4 with CUL4, degron mapping by deletion mutagenesis, protein stability assays, engineered degradation-resistant HOXB4 variants, human HSC transduction and NOD/SCID/IL2Rγ-null mouse transplantation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — co-IP identifies E3 ligase, mutagenesis maps degron, functional rescue with engineered variant in primary human HSCs and in vivo, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"23520338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hoxb4 transduction reduces accumulated Geminin protein in hematopoietic stem and progenitor cells through constituting an E3 ubiquitin ligase complex (RDCOXB4) with Roc1-Ddb1-Cul4a, targeting Geminin for ubiquitin-proteasome degradation; Geminin knockdown promotes clonogenic/replating activity while Geminin overexpression suppresses HOXB4-mediated HSC expansion.\",\n      \"method\": \"Co-immunoprecipitation of HOXB4 with Roc1-Ddb1-Cul4a complex in vitro and in vivo, ubiquitination assays, Geminin overexpression and knockdown, competitive repopulation in Rae28-deficient mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — co-IP identifies complex + functional overexpression/knockdown of downstream target, single lab\",\n      \"pmids\": [\"21098278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"USF1 directs recruitment of the hSET1A histone H3K4 methyltransferase complex to the HoxB4 promoter, establishing H3K4me3 marks and activating HoxB4 transcription during ESC differentiation toward hematopoietic lineages; disruption of USF1 or hSET1A function reduces HoxB4 expression and impairs mesoderm/hematopoietic differentiation.\",\n      \"method\": \"ChIP for H3K4me3 and USF1/hSET1A at HoxB4 promoter, dominant-negative USF1 overexpression, RNA interference knockdown of hSET1A, ESC differentiation assays\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP + gain/loss-of-function in ESC differentiation context, single lab\",\n      \"pmids\": [\"23754954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The TALE homeodomain gene Irx5 is a direct, positively regulated transcriptional target of Hoxb4 in the developing chick embryo.\",\n      \"method\": \"Gain- and loss-of-function manipulation of Hoxb4 in chick embryos with direct readout of Irx5 expression\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single experimental system (chick embryo), limited mechanistic detail in abstract, single lab\",\n      \"pmids\": [\"12701098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Hoxb4 directly induces expression of FLASH (a component of the FAS-CASPASE8 apoptotic pathway) in the notochord after neurulation; blocking FLASH activity or Hoxb4 activity prevents apoptosis in the notochord.\",\n      \"method\": \"Gain- and loss-of-function manipulations of Hoxb4 and FLASH in developing embryos (chick), direct readout of FLASH expression and notochord apoptosis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — functional epistasis in developmental context (chick embryo) with limited mechanistic detail in abstract, single lab\",\n      \"pmids\": [\"14697356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mice homozygous for Hoxb4 deficiency exhibit mildly reduced hematopoietic organ cellularity and impaired proliferative responses of Lin-Sca1+c-kit+ bone marrow stem/progenitor cells in vitro and in vivo after transplantation, with altered expression of other Hox genes and cell cycle regulators. Hoxb4 is not required for HSC generation or steady-state hematopoiesis.\",\n      \"method\": \"Hoxb4 complete knockout mouse model, flow cytometry, competitive transplantation, in vitro culture proliferation, quantitative mRNA analysis, cell cycle assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean gene knockout with multiple functional readouts (proliferation, transplantation, cell cycle), independently complemented by Hoxb3/b4 double KO paper\",\n      \"pmids\": [\"14962901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Hoxb3/Hoxb4 double-deficient mice have reduced hematopoietic stem cell pool in fetal liver and impaired proliferative capacity of Lin-Sca1+c-kit+ progenitors in vitro and in vivo; slower cell cycle kinetics confer increased tolerance to anti-mitotic drugs, establishing a direct physiological role for Hoxb4 (with Hoxb3) in regulating stem cell proliferation and regeneration.\",\n      \"method\": \"Hoxb3/Hoxb4 compound knockout mice, competitive repopulation assay, homing assay, cytostatic drug challenge, flow cytometry, colony assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — compound knockout with multiple functional and mechanistic readouts, clean genetic design\",\n      \"pmids\": [\"12748289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HOXB4 activity protects adult HSCs from the detrimental anti-proliferative effects of TNF-α; FGF signaling interacts with HOXB4 activity in a context-dependent manner (FGF receptor inhibition enhances HOXB4-mediated expansion of adult and ES-derived HSCs, while FGF2 has a dominant-negative effect on the earliest hematopoietic cells). These findings establish that HOXB4 modulates HSC responses to extrinsic signals.\",\n      \"method\": \"Gene expression profiling of inducible HOXB4 in enriched adult HSCs and embryonic derivatives, functional assays with TNF-α treatment and FGF receptor inhibition, competitive repopulation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transcriptome profiling combined with functional validation of specific pathways, single lab\",\n      \"pmids\": [\"17940039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Genome-wide ChIP and expression profiling in ES-cell-derived HSPCs identifies Runx1, Scl/Tal1, Gata2, and Gfi1 as direct transcriptional targets of HoxB4, and reveals indirect regulation of Lmo2, Erg, Meis1, Pbx1, Nov, AhR, and Hemgn. HoxB4 acts predominantly as a transcriptional activator but context-dependently represses a significant subset of direct targets.\",\n      \"method\": \"ChIP-seq (ChIP coupled with deep sequencing) and genome-wide expression profiling in ES-derived hematopoietic stem/progenitor cells expressing inducible HoxB4\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq with expression profiling identifies direct targets, single lab, limited functional validation per target in abstract\",\n      \"pmids\": [\"21343615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Dynamic ChIP-seq and gene expression profiling across four stages of HoxB4-mediated ESC differentiation toward HSCs reveals that the HoxB4 regulatory network expands progressively, HoxB4 co-regulates multiple hematopoietic transcription factors (Fli1, Meis1, Runx1, Scl) in distinct combinations, and down-regulation of mitochondrial and lysosomal genes by HoxB4 may contribute to impaired lymphoid development.\",\n      \"method\": \"ChIP coupled with deep sequencing and global gene expression profiling at 4 differentiation stages, joint bioinformatic analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multi-stage ChIP-seq + expression profiling, single lab, mechanistic conclusions are correlative at the network level\",\n      \"pmids\": [\"22438249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Prdm16 mRNA is markedly repressed as a direct component of the HOXB4 transcriptional program in transplanted HSCs; enforced co-expression of sPrdm16 with HOXB4 leads to enhanced self-renewal, myeloid expansion, and leukemia, establishing Prdm16 downregulation as a specific mechanism by which HOXB4-expanding HSCs avoid leukemic transformation.\",\n      \"method\": \"Time-course gene expression profiling of Lin-Sca1+c-kit+ cells from HOXB4-transplanted mice, co-overexpression of sPrdm16 with HOXB4 by retroviral transduction, murine transplantation leukemia model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — expression profiling plus functional epistasis (co-expression) with leukemia readout, single lab\",\n      \"pmids\": [\"25082879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HoxB4 and STAT3 act in the same pathway for HSC self-renewal: simultaneous transduction of both does not produce additive effects; inhibition of STAT3 in HoxB4-overexpressing cells abrogates HoxB4 enhancement; HoxB4 upregulation causes ligand-independent Tyr-phosphorylation of STAT3; and the two transcription factors regulate significantly overlapping transcriptomes including pluripotency-related genes Oct-4 and Nanog.\",\n      \"method\": \"Retroviral co-transduction of STAT3-C and HoxB4, competitive repopulation assay, STAT3 pharmacological inhibition, phospho-STAT3 Western blot, microarray transcriptome analysis, gene set enrichment analysis\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis by co-expression and inhibition plus phosphorylation assay and transcriptome overlap, single lab\",\n      \"pmids\": [\"24446131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"miR-23a directly binds the 3'UTR of HOXB4 mRNA and represses HOXB4 protein expression by ~65%, as demonstrated by luciferase reporter assay and Western blot.\",\n      \"method\": \"Luciferase 3'UTR reporter assay with miR-23a, Western blot for HOXB4 protein after miR-23a transfection\",\n      \"journal\": \"Genes, chromosomes & cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase 3'UTR assay plus Western blot validation, single lab\",\n      \"pmids\": [\"23630040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A proline-rich sequence near the N-terminus of HOXB4, unique among HOX proteins and highly conserved in higher mammals, is required for controlled stem cell amplification: deletion of this domain substantially enhances HOXB4's oncogenicity causing acute leukemia in mice; insertion of the domain into HOXA9 impairs HOXA9's leukemogenicity.\",\n      \"method\": \"Domain deletion and domain-swap mutagenesis of HOXB4/HOXA9, retroviral transduction into murine bone marrow, transplantation with leukemia monitoring, in vivo stem cell expansion assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — domain mutagenesis with reciprocal domain-swap between paralogs + in vivo leukemia readout, establishes clear structure-function relationship\",\n      \"pmids\": [\"27827825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IGF2BP1 maintains HOXB4 mRNA stability in leukemia cells; IGF2BP1 inhibition reduces HOXB4 expression and decreases leukemia cell tumorigenicity, myeloid differentiation block, and chemotherapy resistance.\",\n      \"method\": \"CLIP and PAR-CLIP to identify HOXB4 as an IGF2BP1 RNA target, gain- and loss-of-function systems for IGF2BP1 in leukemia cell lines, tumor-initiating potential assays\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CLIP/PAR-CLIP identifying mRNA target + gain/loss-of-function functional assays, single lab\",\n      \"pmids\": [\"31768017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HOXB4 directly transcriptionally represses β-catenin expression, thereby inactivating the Wnt/β-catenin signaling pathway in cervical cancer cells; re-expression of β-catenin rescues HOXB4-induced growth inhibition.\",\n      \"method\": \"ChIP or reporter assays for HOXB4 binding to β-catenin promoter, gain/loss-of-function of HOXB4 in cervical cancer cells, β-catenin rescue experiment, nude mouse xenograft\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic rescue experiment + binding assay + in vivo xenograft, single lab\",\n      \"pmids\": [\"33479226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HOXB4 activates DHDDS transcription by binding to two DNA motifs in the DHDDS gene, contributing to ovarian cancer proliferation and invasion; HOXB4 also induces Snail and Zeb1 expression (EMT markers).\",\n      \"method\": \"ChIP assay for HOXB4 binding to DHDDS promoter motifs, HOXB4 gain/loss-of-function in ovarian cancer cells, xenograft mouse model\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP validates direct target binding + functional gain/loss-of-function + in vivo xenograft, single lab\",\n      \"pmids\": [\"32178630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HOXB4 binds to the LINC00629 promoter and transcriptionally represses LINC00629 expression in ovarian cancer cells.\",\n      \"method\": \"ChIP assay for HOXB4 binding to the LINC00629 promoter, correlation of HOXB4 expression with LINC00629 levels\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single ChIP assay, limited functional validation of HOXB4's direct role distinct from downstream lncRNA effects\",\n      \"pmids\": [\"38182548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HOXB4 serves as a transcriptional activator of AKR1C3 and can suppress erastin-induced ferroptosis in H9C2 cardiomyocytes.\",\n      \"method\": \"Luciferase reporter assay for HOXB4 transactivation of AKR1C3, ferroptosis characteristic measurements (GPX4, MDA, iron, GSH) in HOXB4-transfected H9C2 cells\",\n      \"journal\": \"Frontiers in cardiovascular medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single reporter assay + cellular ferroptosis measurements, single lab, limited mechanistic detail\",\n      \"pmids\": [\"34568444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"HOXB4 promotes hemogenic endothelium formation from differentiating mouse ESCs without altering endothelial cell development; whole-transcriptome analysis shows HOXB4 upregulates core hematopoietic transcription factors at the hemogenic endothelium stage, with blood progenitor formation requiring subsequent Runx1 expression.\",\n      \"method\": \"Retroviral HOXB4 expression in Runx1-/- ESCs with doxycycline-inducible Runx1, flow cytometric identification of hemogenic endothelium, whole-transcriptome analysis\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic dissection using Runx1-null ESCs + inducible Runx1 + transcriptome analysis identifies specific cellular stage of HOXB4 action, single lab\",\n      \"pmids\": [\"29456178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HOXB4 overexpression in large animals (dogs, macaques) caused myeloid leukemia ~2 years post-transplantation with dysregulated oncogene expression and a block in myeloid differentiation; HOXB4 knockdown in leukemic cells restored differentiation, suggesting direct HOXB4 involvement. Control gammaretroviral vectors (expressing MGMT or no transgene) did not cause leukemia.\",\n      \"method\": \"Retroviral HOXB4 transduction in large animal HSCs (dog, macaque), long-term transplantation monitoring, leukemia characterization (blast immunophenotyping, oncogene expression profiling), HOXB4 shRNA knockdown of leukemic cells\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — large animal model with long-term follow-up + HOXB4 knockdown rescue of differentiation block, small animal numbers limit strength\",\n      \"pmids\": [\"18357342\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HOXB4 is a homeodomain transcription factor that promotes hematopoietic stem cell self-renewal and expansion through direct DNA binding (independent of HOX-PBX cooperative interaction); its transcription is activated by USF1/USF2 (via MAP kinase and p38 pathways) and NF-Y at its promoter, while Prep1-4EHP represses its translation via the 3'UTR; at the protein level, HOXB4 is rapidly degraded by the CUL4 ubiquitin ligase through a conserved homeodomain degron, and also forms an E3 ligase complex (RDCOXB4 with Roc1-Ddb1-Cul4a) to ubiquitinate Geminin and promote HSC proliferation; its direct transcriptional targets include hematopoietic master regulators (Runx1, Scl/Tal1, Gata2, Gfi1) and downstream effectors such as Hemgn, and it represses Prdm16 to prevent leukemic transformation; a unique N-terminal proline-rich domain restrains its oncogenic potential; in non-hematopoietic contexts HOXB4 directly represses β-catenin (Wnt pathway) and activates DHDDS and AKR1C3 transcription, and during hindbrain development it is induced by somite-derived retinoic acid signaling through a RARE in its prerhombomeric enhancer.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HOXB4 is a homeodomain transcription factor that acts as a master positive regulator of hematopoietic stem cell (HSC) self-renewal and proliferation, expanding the most primitive transplantable HSC compartment without disrupting lineage differentiation [#0, #2]. Its expansion activity requires direct DNA binding by the homeodomain but is independent of, and even enhanced by loss of, the HOX-PBX cooperative interaction [#7]; the protein is membrane-permeant, such that recombinant or stroma-secreted HOXB4 expands both murine and human HSCs without genetic modification [#4, #5]. Crucially, HOXB4 does not override homeostatic ceilings on HSC pool size, restoring rather than exceeding normal HSC numbers in vivo [#12], and loss-of-function studies show it is dispensable for HSC generation yet required for full proliferative capacity of stem/progenitor cells, acting redundantly with paralogous group-4 Hox genes [#26, #27, #11]. Mechanistically, HOXB4 directly binds and activates a network of hematopoietic master regulators—Runx1, Scl/Tal1, Gata2, Gfi1—and the downstream effector Hemgn, while acting context-dependently as a repressor of a subset of targets [#29, #20]; it drives hemogenic endothelium formation upstream of Runx1 [#40] and signals through a shared pathway with STAT3 [#32]. HOXB4 transcription is controlled at its promoter by USF1/USF2 acting through MAP kinase/p38 signaling downstream of thrombopoietin, with USF1 recruiting the hSET1A H3K4 methyltransferase complex, and by the trimeric NF-Y complex, which physically associates with USF1/2 [#8, #13, #9, #23]. The protein is held under tight control: it has a short half-life imposed by CUL4-mediated ubiquitination of a conserved homeodomain degron [#21], and it conversely assembles a Roc1-Ddb1-Cul4a E3 ligase complex to degrade Geminin and promote proliferation [#22]. HOXB4 limits its own oncogenic potential through a unique conserved N-terminal proline-rich domain and by repressing Prdm16, with deletion of the proline-rich domain or co-expression of Prdm16 converting HOXB4 into a leukemogenic driver [#34, #31, #41]. In non-hematopoietic and developmental contexts, HOXB4 expression is initiated in the hindbrain by somite-derived retinoic acid acting through a RARE in a prerhombomeric enhancer [#10], and it functions as a context-dependent transcriptional regulator, directly repressing \\u03b2-catenin to inhibit Wnt signaling in cervical cancer and activating DHDDS in ovarian cancer [#36, #37].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established the foundational function of HOXB4 by asking whether a HOX gene could regulate HSC numbers, showing it selectively expands the primitive stem cell compartment.\",\n      \"evidence\": \"Retroviral overexpression in murine bone marrow with serial transplantation and limit-dilution repopulation assays\",\n      \"pmids\": [\"7622039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets unidentified\", \"Mechanism distinguishing self-renewal from differentiation unclear\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Defined the physiological developmental role and revealed functional redundancy by asking what group-4 Hox genes are required for, showing dose-dependent vertebral transformations only in compound mutants.\",\n      \"evidence\": \"Targeted gene disruption generating double and triple Hox group-4 compound mutant mice with skeletal analysis\",\n      \"pmids\": [\"7628700\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address hematopoietic requirement\", \"Molecular targets in skeletal patterning not defined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Addressed how HOXB4 is positioned in the embryo by identifying the upstream inducing signal, showing retinoic acid from somites sets the anterior expression boundary via a RARE.\",\n      \"evidence\": \"Chick/mouse tissue transposition, RAR inhibition, and enhancer-reporter transgenics with RARE mutagenesis\",\n      \"pmids\": [\"9697850\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hematopoietic regulation distinct from this neural enhancer\", \"Downstream neural targets not defined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Tested which protein domains mediate HOXB4 activity in a transformation context, showing dependence on both the tetrapeptide HOX-PBX interaction domain and the homeodomain.\",\n      \"evidence\": \"Rat-1 fibroblast transformation assay with HOXB4 domain mutants and PBX1 modulation\",\n      \"pmids\": [\"9692548\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Fibroblast transformation may not reflect HSC mechanism\", \"PBX1 requirement later shown dispensable in HSCs\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Asked whether HOXB4 acts ex vivo and on embryonic progenitors, demonstrating massive ex vivo HSC expansion and conferral of definitive engraftment potential on primitive progenitors.\",\n      \"evidence\": \"Retroviral overexpression in bone marrow, ES/yolk-sac progenitors, stromal co-culture, and competitive repopulation assays\",\n      \"pmids\": [\"11955444\", \"11955445\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional program driving expansion unknown\", \"Mechanism of definitive switch not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved whether HOXB4 protein itself suffices, showing membrane-permeant recombinant and stroma-secreted HOXB4 expand murine and human HSCs without gene transfer.\",\n      \"evidence\": \"TAT-HOXB4 protein transduction and stroma-secreted HOXB4 co-culture with murine and human HSCs, in vivo repopulation\",\n      \"pmids\": [\"14578881\", \"14578882\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of passive membrane translocation not detailed\", \"Magnitude lower than retroviral delivery\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Connected HOXB4 transcription to extrinsic cytokine signaling by showing thrombopoietin induces it via p38 MAPK and USF-1.\",\n      \"evidence\": \"TPO stimulation, p38 inhibition, USF-1 activation assays, and tpo-/- mouse mRNA quantification\",\n      \"pmids\": [\"12855555\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Quantitative contribution of TPO to physiological HOXB4 levels modest (2-5 fold)\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified the proximal transcriptional activators of HOXB4 by asking what binds its promoter E-box, showing USF-1/USF-2 activate via the MAP kinase pathway.\",\n      \"evidence\": \"Yeast one-hybrid screen, EMSA, promoter mutagenesis, and luciferase assays in K562/CD34+ cells\",\n      \"pmids\": [\"11085749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MITF binds the same site without activating, function unexplained\", \"In vivo promoter occupancy not addressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Expanded the promoter model by identifying NF-Y as a developmentally regulated activator that physically partners with USF1/2.\",\n      \"evidence\": \"EMSA, ChIP, dominant-negative NF-Y, and co-immunoprecipitation of NF-Y/USF1/2\",\n      \"pmids\": [\"12791656\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking NF-Ya decline to differentiation incomplete\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Determined the dominant domain requirement for HSC expansion in vivo, showing direct DNA binding is essential while HOX-PBX cooperativity is dispensable and limiting.\",\n      \"evidence\": \"Retroviral DNA-binding-incompetent and PBX-interaction-deficient HOXB4 mutants with PBX1 knockdown and competitive repopulation\",\n      \"pmids\": [\"15226173\", \"12705858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Non-cell-autonomous mechanism limiting expansion unidentified\", \"Direct in vivo target genes not yet mapped\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Established a non-self-renewal transcriptional function by asking how vitamin D3 suppresses c-myc, identifying HOXB4 as the MIE1-binding factor blocking c-myc elongation.\",\n      \"evidence\": \"EMSA protein identification, c-myc reporter assays, PKC\\u03b2 inhibition, and antisense HOXB4 knockdown in HL-60\",\n      \"pmids\": [\"10085075\", \"11250656\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell-line system\", \"Relationship to HSC role unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed translational control of HOXB4 by showing cytoplasmic Prep1-4EHP represses Hoxb4 mRNA via its 3'UTR.\",\n      \"evidence\": \"Co-IP, pulldown, 4EHP-motif mutagenesis, in vitro translation with Hoxb4-3'UTR reporter, and Prep1 hypomorph mice\",\n      \"pmids\": [\"19365557\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Demonstrated in oocytes; relevance to hematopoiesis untested\", \"Single study\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Began defining the HOXB4 downstream program by identifying Hemgn as a direct target that partially mediates myeloid expansion.\",\n      \"evidence\": \"Inducible HOXB4-ER, expression microarray, ChIP at Hemgn promoter, and Hemgn gain/loss-of-function colony assays\",\n      \"pmids\": [\"20393131\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hemgn only partially recapitulates HOXB4 effect\", \"Other targets needed for full activity\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Uncovered a non-transcriptional role for HOXB4 as part of an E3 ligase, showing it assembles RDCOXB4 (Roc1-Ddb1-Cul4a) to degrade Geminin and promote proliferation.\",\n      \"evidence\": \"Co-IP of the Roc1-Ddb1-Cul4a complex, ubiquitination assays, and Geminin gain/loss-of-function with competitive repopulation\",\n      \"pmids\": [\"21098278\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Structural basis of complex assembly unknown\", \"Relation to transcriptional activity unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapped the genome-wide direct target network, identifying Runx1, Scl/Tal1, Gata2 and Gfi1 as direct targets and showing context-dependent activation versus repression.\",\n      \"evidence\": \"ChIP-seq and genome-wide expression profiling in ES-derived HSPCs with inducible HoxB4\",\n      \"pmids\": [\"21343615\", \"22438249\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Per-target functional validation limited\", \"Determinants of activation versus repression unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established post-translational and chromatin-level layers of regulation: CUL4 degrades HOXB4 via a conserved homeodomain degron, while USF1 recruits hSET1A to deposit activating H3K4me3.\",\n      \"evidence\": \"Co-IP with CUL4, degron mapping, degradation-resistant variants in human HSC transplants, and ChIP for H3K4me3/USF1/hSET1A in ESC differentiation\",\n      \"pmids\": [\"23520338\", \"23754954\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Degron degradation signal and E3 substrate-recognition details incomplete\", \"Single labs\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined how HOXB4 expansion is decoupled from leukemia, showing repression of Prdm16 prevents transformation and placing HoxB4 in a shared STAT3 self-renewal pathway.\",\n      \"evidence\": \"Expression profiling and sPrdm16 co-expression leukemia model; STAT3 co-transduction/inhibition with phospho-STAT3 and transcriptome overlap\",\n      \"pmids\": [\"25082879\", \"24446131\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of STAT3 ligand-independent phosphorylation unknown\", \"Direct versus indirect Prdm16 repression not fully resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified the structural basis restraining oncogenicity, showing a unique conserved N-terminal proline-rich domain limits stem cell amplification.\",\n      \"evidence\": \"Domain deletion and reciprocal HOXB4/HOXA9 domain-swap mutagenesis with in vivo leukemia monitoring\",\n      \"pmids\": [\"27827825\", \"18357342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular partners of the proline-rich domain unknown\", \"Mechanism by which it restrains amplification undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended HOXB4 function to non-hematopoietic cancer contexts, showing direct transcriptional regulation of \\u03b2-catenin, DHDDS, and additional targets.\",\n      \"evidence\": \"ChIP/reporter binding assays, gain/loss-of-function, rescue, and xenografts in cervical and ovarian cancer cells\",\n      \"pmids\": [\"33479226\", \"32178630\", \"31768017\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Context determinants of repression versus activation unclear\", \"Single labs per tumor type\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The integration of HOXB4's transcriptional, E3-ligase, and translational/post-translational regulatory layers into a unified model of how the HSC expansion ceiling is enforced remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The non-cell-autonomous mechanism capping HSC expansion is unidentified\", \"How direct DNA targets, Geminin degradation, and STAT3 signaling converge mechanistically is unknown\", \"Physiological relevance of Prep1-4EHP and miR-23a/IGF2BP1 mRNA regulation in HSCs untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 7, 20, 29, 36, 37]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [7, 18, 20, 29]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [14, 20, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 20, 29]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10, 11, 40]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [21, 22]}\n    ],\n    \"complexes\": [\"RDCOXB4 (Roc1-Ddb1-Cul4a E3 ligase)\"],\n    \"partners\": [\"PBX1\", \"USF1\", \"USF2\", \"NFYA\", \"CUL4\", \"Geminin\", \"Prep1\", \"STAT3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}